<!DOCTYPE html>
<html lang="en" class="no-js">
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="applicable-device" content="pc,mobile">
        <meta name="viewport" content="width=device-width, initial-scale=1">

        <title>JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer | Breast Cancer Research | Full Text</title>

        

    <meta name="citation_abstract" content="We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer. Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. JMJD6 emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-based assays elucidated molecular mechanisms of JMJD6 action in breast cancer progression and shed light on the clinical breast cancer subtypes relevant to JMJD6 action. 
JMJD6 was expressed at highest levels in tumors associated with worse outcomes, including ER- and basal-like, Claudin-low, Her2-enriched, and ER+ Luminal B tumors. High nuclear JMJD6 protein was associated with ER negativity, advanced grade, and poor differentiation in tissue microarrays. Separation of ER+/LN- patients that received endocrine monotherapy indicated that JMJD6 is predictive of poor outcome in treatment-specific subgroups. In breast cancer cell lines, loss of JMJD6 consistently resulted in suppressed proliferation but not apoptosis, whereas forced stable overexpression increased growth. In addition, knockdown of JMJD6 in invasive cell lines, such as MDA-MB231, decreased motility and invasion, whereas overexpression in MCF-7 cells slightly promoted motility but did not confer invasive growth. Microarray analysis showed that the most significant transcriptional changes occurred in cell-proliferation genes and genes of the TGF-&#946; tumor-suppressor pathway. High proliferation was characterized by constitutively high cyclin E protein levels. The inverse relation of JMJD6 expression with TGF-&#946;

                    2
                   could be extrapolated to the breast cancer cohorts, suggesting that JMJD6 may affect similar pathways in primary breast cancer. 
JMJD6 is a novel biomarker of tumor aggressiveness with functional implications in breast cancer growth and migration.">

    <meta name="journal_id" content="13058">

    <meta name="dc.title" content="JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer">

    <meta name="dc.source" content="Breast Cancer Research 2012 14:3">

    <meta name="dc.format" content="text/html">

    <meta name="dc.publisher" content="BioMed Central">

    <meta name="dc.date" content="2012-05-23">

    <meta name="dc.type" content="OriginalPaper">

    <meta name="dc.language" content="En">

    <meta name="dc.copyright" content="2012 Desai et al.; licensee BioMed Central Ltd.">

    <meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0">

    <meta name="dc.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="dc.description" content="We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer. Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. JMJD6 emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-based assays elucidated molecular mechanisms of JMJD6 action in breast cancer progression and shed light on the clinical breast cancer subtypes relevant to JMJD6 action. JMJD6 was expressed at highest levels in tumors associated with worse outcomes, including ER- and basal-like, Claudin-low, Her2-enriched, and ER+ Luminal B tumors. High nuclear JMJD6 protein was associated with ER negativity, advanced grade, and poor differentiation in tissue microarrays. Separation of ER+/LN- patients that received endocrine monotherapy indicated that JMJD6 is predictive of poor outcome in treatment-specific subgroups. In breast cancer cell lines, loss of JMJD6 consistently resulted in suppressed proliferation but not apoptosis, whereas forced stable overexpression increased growth. In addition, knockdown of JMJD6 in invasive cell lines, such as MDA-MB231, decreased motility and invasion, whereas overexpression in MCF-7 cells slightly promoted motility but did not confer invasive growth. Microarray analysis showed that the most significant transcriptional changes occurred in cell-proliferation genes and genes of the TGF-&#946; tumor-suppressor pathway. High proliferation was characterized by constitutively high cyclin E protein levels. The inverse relation of JMJD6 expression with TGF-&#946; 2 could be extrapolated to the breast cancer cohorts, suggesting that JMJD6 may affect similar pathways in primary breast cancer. JMJD6 is a novel biomarker of tumor aggressiveness with functional implications in breast cancer growth and migration.">

    <meta name="prism.issn" content="1465-542X">

    <meta name="prism.publicationName" content="Breast Cancer Research">

    <meta name="prism.publicationDate" content="2012-05-23">

    <meta name="prism.volume" content="14">

    <meta name="prism.number" content="3">

    <meta name="prism.section" content="OriginalPaper">

    <meta name="prism.startingPage" content="1">

    <meta name="prism.endingPage" content="16">

    <meta name="prism.copyright" content="2012 Desai et al.; licensee BioMed Central Ltd.">

    <meta name="prism.rightsAgent" content="reprints@biomedcentral.com">

    <meta name="prism.url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3200">

    <meta name="prism.doi" content="doi:10.1186/bcr3200">

    <meta name="citation_pdf_url" content="https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3200">

    <meta name="citation_fulltext_html_url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3200">

    <meta name="citation_journal_title" content="Breast Cancer Research">

    <meta name="citation_journal_abbrev" content="Breast Cancer Res">

    <meta name="citation_publisher" content="BioMed Central">

    <meta name="citation_issn" content="1465-542X">

    <meta name="citation_title" content="JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer">

    <meta name="citation_volume" content="14">

    <meta name="citation_issue" content="3">

    <meta name="citation_publication_date" content="2012/06">

    <meta name="citation_online_date" content="2012/05/23">

    <meta name="citation_firstpage" content="1">

    <meta name="citation_lastpage" content="16">

    <meta name="citation_article_type" content="Research article">

    <meta name="citation_fulltext_world_readable" content="">

    <meta name="citation_language" content="en">

    <meta name="dc.identifier" content="doi:10.1186/bcr3200">

    <meta name="DOI" content="10.1186/bcr3200">

    <meta name="citation_doi" content="10.1186/bcr3200">

    <meta name="description" content="We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer. Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. JMJD6 emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-based assays elucidated molecular mechanisms of JMJD6 action in breast cancer progression and shed light on the clinical breast cancer subtypes relevant to JMJD6 action. JMJD6 was expressed at highest levels in tumors associated with worse outcomes, including ER- and basal-like, Claudin-low, Her2-enriched, and ER+ Luminal B tumors. High nuclear JMJD6 protein was associated with ER negativity, advanced grade, and poor differentiation in tissue microarrays. Separation of ER+/LN- patients that received endocrine monotherapy indicated that JMJD6 is predictive of poor outcome in treatment-specific subgroups. In breast cancer cell lines, loss of JMJD6 consistently resulted in suppressed proliferation but not apoptosis, whereas forced stable overexpression increased growth. In addition, knockdown of JMJD6 in invasive cell lines, such as MDA-MB231, decreased motility and invasion, whereas overexpression in MCF-7 cells slightly promoted motility but did not confer invasive growth. Microarray analysis showed that the most significant transcriptional changes occurred in cell-proliferation genes and genes of the TGF-&#946; tumor-suppressor pathway. High proliferation was characterized by constitutively high cyclin E protein levels. The inverse relation of JMJD6 expression with TGF-&#946; 2 could be extrapolated to the breast cancer cohorts, suggesting that JMJD6 may affect similar pathways in primary breast cancer. JMJD6 is a novel biomarker of tumor aggressiveness with functional implications in breast cancer growth and migration.">

    <meta name="dc.creator" content="Lee, Yi Fang">

    <meta name="dc.creator" content="Miller, Lance David">

    <meta name="dc.creator" content="Chan, Xiu Bin">

    <meta name="dc.creator" content="Black, Michael A">

    <meta name="dc.creator" content="Pang, Brendan">

    <meta name="dc.creator" content="Ong, Chee Wee">

    <meta name="dc.creator" content="Salto-Tellez, Manuel">

    <meta name="dc.creator" content="Liu, Edison T">

    <meta name="dc.creator" content="Desai, Kartiki V">

    <meta name="dc.subject" content="Cancer Research">

    <meta name="dc.subject" content="Oncology">

    <meta name="dc.subject" content="Surgical Oncology">

    <meta name="citation_reference" content="citation_journal_title=EMBO Mol Med; citation_title=Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer; citation_author=WWML Soon, MA Black, C Dalmasso, XB Chan, B Pang, CW Ong, M Salto-Tellez, K Desai, ET Liu; citation_volume=3; citation_publication_date=2011; citation_pages=451-464; citation_doi=10.1002/emmm.201100150; citation_id=CR1_3001">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A receptor for phosphatidylserine-specific clearance of apoptotic cells; citation_author=VA Fadok, DL Bratton, DM Rose, A Pearson, RAB Ezekewitz, PM Henson; citation_volume=405; citation_publication_date=2000; citation_pages=85-90; citation_doi=10.1038/35011084; citation_id=CR2_3001">

    <meta name="citation_reference" content="citation_journal_title=J Biol; citation_title=The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal; citation_author=J Bose, A Gruber, L Helming, S Schiebe, I Wegener, M Hafner, M Beales, F Kontgen, A Lengeling; citation_volume=3; citation_publication_date=2004; citation_pages=15; citation_doi=10.1186/jbiol10; citation_id=CR3_3001">

    <meta name="citation_reference" content="citation_journal_title=Exp Cell Res; citation_title=Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals; citation_author=P Cui, B Qin, N Liu, G Pan, D Pei; citation_volume=293; citation_publication_date=2004; citation_pages=154-163; citation_doi=10.1016/j.yexcr.2003.09.023; citation_id=CR4_3001">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=JMJD6 Is a histone arginine demethylase; citation_author=B Chang, Y Chen, Y Zhao, RK Bruick; citation_volume=318; citation_publication_date=2007; citation_pages=444-447; citation_doi=10.1126/science.1145801; citation_id=CR5_3001">

    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing; citation_author=CJ Webby, A Wolf, N Gromak, M Dreger, H Kramer, B Kessler, ML Nielsen, C Schmitz, DS Butler, JR Yates, CM Delahunty, P Hahn, A Lengeling, M Mann, NJ Proudfoot, CJ Schofield, A B&#246;ttger; citation_volume=325; citation_publication_date=2009; citation_pages=90-93; citation_doi=10.1126/science.1175865; citation_id=CR6_3001">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1; citation_author=J-N Boeckel, V Guarani, M Koyanagi, T Roexe, A Lengeling, RT Schermuly, P Gellert, T Braun, A Zeiher, S Dimmeler; citation_volume=108; citation_publication_date=2011; citation_pages=3276-3281; citation_doi=10.1073/pnas.1008098108; citation_id=CR7_3001">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Interaction of JMJD6 with single-stranded RNA; citation_author=X Hong, J Zang, J White, C Wang, CH Pan, R Zhao, RC Murphy, S Dai, P Henson, JW Kappler, J Hagman, G Zhang; citation_volume=107; citation_publication_date=2010; citation_pages=14568-14572; citation_doi=10.1073/pnas.1008832107; citation_id=CR8_3001">

    <meta name="citation_reference" content="citation_inbook_title=R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; citation_publication_date=2010; citation_id=CR9_3001">

    <meta name="citation_reference" content="citation_journal_title=Genome Biol; citation_title=Bioconductor: open software development for computational biology and bioinformatics; citation_author=RC Gentleman, VJ Carey, DM Bates, B Bolstad, M Dettling, S Dudoit, B Ellis, L Gautier, Y Ge, J Gentry, K Hornik, T Hothorn, W Huber, S Iacus, R Irizarry, F Leisch, C Li, M Maechler, AJ Rossini, G Sawitzki, C Smith, G Smyth, L Tierney, JY Yang, J Zhang; citation_volume=5; citation_publication_date=2004; citation_pages=R80; citation_doi=10.1186/gb-2004-5-10-r80; citation_id=CR10_3001">

    <meta name="citation_reference" content="citation_journal_title=Biostatistics; citation_title=Adjusting batch effects in microarray expression data using empirical Bayes methods; citation_author=C Li, A Rabinovic; citation_volume=8; citation_publication_date=2007; citation_pages=118-127; citation_doi=10.1093/biostatistics/kxj037; citation_id=CR11_3001">

    <meta name="citation_reference" content="citation_journal_title=J Clin Oncol; citation_title=Supervised risk predictor of breast cancer based on intrinsic subtypes; citation_author=JS Parker, M Mullins, MC Cheang, S Leung, D Voduc, T Vickery, S Davies, C Fauron, X He, Z Hu, JF Quackenbush, IJ Stijleman, J Palazzo, JS Marron, AB Nobel, E Mardis, TO Nielsen, MJ Ellis, CM Perou, PS Bernard; citation_volume=27; citation_publication_date=2009; citation_pages=1160-1167; citation_doi=10.1200/JCO.2008.18.1370; citation_id=CR12_3001">

    <meta name="citation_reference" content="
UNC Microarray Database
[
                    https://genome.unc.edu/pubsup/breastGEO
                    
                  ]">

    <meta name="citation_reference" content="citation_journal_title=Breast Cancer Res; citation_title=Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer; citation_author=A Prat, J Parker, O Karginova, C Fan, C Livasy, J Herschkowitz, X He, C Perou; citation_volume=12; citation_publication_date=2010; citation_pages=R68; citation_doi=10.1186/bcr2635; citation_id=CR14_3001">

    <meta name="citation_reference" content="
SigmaPlot for Windows 11.0th edition. Systat Software, Inc., San Jose, CA; 2008.">

    <meta name="citation_reference" content="citation_journal_title=Br J Cancer; citation_title=Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours; citation_author=M Salto-Tellez, ME Nga, HC Han, AS Wong, CK Lee, D Anuar, SS Ng, M Ho, A Wee, YH Chan, R Soong; citation_volume=96; citation_publication_date=2007; citation_pages=776-782; citation_doi=10.1038/sj.bjc.6603551; citation_id=CR16_3001">

    <meta name="citation_reference" content="citation_journal_title=Pathology; citation_title=TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery; citation_author=K Das, MF Mohd Omar, CW Ong, S Bin Abdul Rashid, BK Peh, TC Putti, PH Tan, KS Chia, M Teh, N Shah, R Soong, M Salto-Tellez; citation_volume=40; citation_publication_date=2008; citation_pages=441-449; citation_doi=10.1080/00313020802198101; citation_id=CR17_3001">

    <meta name="citation_reference" content="
PASW Statistics 18 18.0.0 edition. Chicago: SPSS Inc.; 2009.">

    <meta name="citation_reference" content="citation_journal_title=Cancer Res; citation_title=Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells; citation_author=M Shtutman, E Levina, P Ohouo, M Baig, IB Roninson; citation_volume=66; citation_publication_date=2006; citation_pages=11370-11380; citation_doi=10.1158/0008-5472.CAN-06-2106; citation_id=CR19_3001">

    <meta name="citation_reference" content="
Ingenuity Systems
[
                    http://www.ingenuity.com
                    
                  ]">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Cluster analysis and display of genome-wide expression patterns; citation_author=MB Eisen, PT Spellman, PO Brown, D Botstein; citation_volume=95; citation_publication_date=1998; citation_pages=14863-14868; citation_doi=10.1073/pnas.95.25.14863; citation_id=CR21_3001">

    <meta name="citation_reference" content="citation_title=TreeView; citation_publication_date=2002; citation_id=CR22_3001; citation_author=M Eisen">

    <meta name="citation_reference" content="citation_journal_title=Genome Biol; citation_title=Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors; citation_author=JI Herschkowitz, K Simin, VJ Weigman, I Mikaelian, J Usary, Z Hu, KE Rasmussen, LP Jones, S Assefnia, S Chandrasekharan, MG Backlund, Y Yin, AI Khramtsov, R Bastein, J Quackenbush, RI Glazer, PH Brown, JE Green, L Kopelovich, PA Furth, JP Palazzo, OI Olopade, PS Bernard, GA Churchill, T Van Dyke, CM Perou; citation_volume=8; citation_publication_date=2007; citation_pages=R76; citation_doi=10.1186/gb-2007-8-5-r76; citation_id=CR23_3001">

    <meta name="citation_reference" content="citation_journal_title=Eur J Cancer; citation_title=Molecular portraits of breast cancer: tumour subtypes as distinct disease entities; citation_author=T S&#248;rlie; citation_volume=40; citation_publication_date=2004; citation_pages=2667-2675; citation_doi=10.1016/j.ejca.2004.08.021; citation_id=CR24_3001">

    <meta name="citation_reference" content="citation_journal_title=Mol Reprod Dev; citation_title=TGF-beta regulation of epithelial cell proliferation; citation_author=HL Moses; citation_volume=32; citation_publication_date=1992; citation_pages=179-184; citation_doi=10.1002/mrd.1080320215; citation_id=CR25_3001">

    <meta name="citation_reference" content="citation_journal_title=J Endocrinol; citation_title=Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium; citation_author=CN Robson, V Gnanapragasam, RL Byrne, AT Collins, DE Neal; citation_volume=160; citation_publication_date=1999; citation_pages=257-266; citation_doi=10.1677/joe.0.1600257; citation_id=CR26_3001">

    <meta name="citation_reference" content="citation_journal_title=Adv Cancer Res; citation_title=Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta; citation_author=MJWC Ravitz; citation_volume=71; citation_publication_date=1997; citation_pages=165-207; citation_doi=10.1016/S0065-230X(08)60099-8; citation_id=CR27_3001">

    <meta name="citation_reference" content="citation_journal_title=J Clin Invest; citation_title=Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression; citation_author=CL Arteaga, SD Hurd, AR Winnier, MD Johnson, BM Fendly, JT Forbes; citation_volume=92; citation_publication_date=1993; citation_pages=2569-2576; citation_doi=10.1172/JCI116871; citation_id=CR28_3001">

    <meta name="citation_reference" content="citation_journal_title=J Cell Biochem; citation_title=Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1; citation_author=H Ji, LE Stout, Q Zhang, R Zhang, HT Leung, BS Leung; citation_volume=54; citation_publication_date=1994; citation_pages=332-342; citation_doi=10.1002/jcb.240540309; citation_id=CR29_3001">

    <meta name="citation_reference" content="citation_journal_title=J Biol Chem; citation_title=Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-&#946;(TGF-&#946;) and the type II TGF-&#946; receptor; citation_author=S Fanayan, SM Firth, AJ Butt, RC Baxter; citation_volume=275; citation_publication_date=2000; citation_pages=39146-39151; citation_doi=10.1074/jbc.M006964200; citation_id=CR30_3001">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor &#946; growth arrest program; citation_author=CR Chen, Y Kang, J Massagu&#233;; citation_volume=98; citation_publication_date=2001; citation_pages=992-999; citation_doi=10.1073/pnas.98.3.992; citation_id=CR31_3001">

    <meta name="citation_reference" content="citation_journal_title=Development; citation_title=TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes; citation_author=LP Sanford, I Ormsby, AC Gittenberger-de Groot, H Sariola, R Friedman, GP Boivin, EL Cardell, T Doetschman; citation_volume=124; citation_publication_date=1997; citation_pages=2659-2670; citation_id=CR32_3001">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases; citation_author=Y Geng, RA Weinberg; citation_volume=90; citation_publication_date=1993; citation_pages=10315-10319; citation_doi=10.1073/pnas.90.21.10315; citation_id=CR33_3001">

    <meta name="citation_reference" content="citation_journal_title=Immunol Lett; citation_title=Mechanisms of TGF-[beta] signaling in regulation of cell growth and differentiation; citation_author=A Moustakas, K Pardali, A Gaal, C-H Heldin; citation_volume=82; citation_publication_date=2002; citation_pages=85-91; citation_doi=10.1016/S0165-2478(02)00023-8; citation_id=CR34_3001">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism; citation_author=MB Datto, Y Li, JF Panus, DJ Howe, Y Xiong, XF Wang; citation_volume=92; citation_publication_date=1995; citation_pages=5545-5549; citation_doi=10.1073/pnas.92.12.5545; citation_id=CR35_3001">

    <meta name="citation_reference" content="citation_journal_title=N Engl J Med; citation_title=Cyclin E and survival in patients with breast cancer; citation_author=K Keyomarsi, SL Tucker, TA Buchholz, M Callister, Y Ding, GN Hortobagyi, I Bedrosian, C Knickerbocker, W Toyofuku, M Lowe, TW Herliczek, SS Bacus; citation_volume=347; citation_publication_date=2002; citation_pages=1566-1575; citation_doi=10.1056/NEJMoa021153; citation_id=CR36_3001">

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Deregulated cyclin E induces chromosome instability; citation_author=CH Spruck, K-A Won, SI Reed; citation_volume=401; citation_publication_date=1999; citation_pages=297-300; citation_doi=10.1038/45836; citation_id=CR37_3001">

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci USA; citation_title=Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients; citation_author=M Scaltriti, PJ Eichhorn, J Cort&#233;s, L Prudkin, C Aura, J Jim&#233;nez, S Chandarlapaty, V Serra, A Prat, YH Ibrahim, M Guzm&#225;n, M Gili, O Rodr&#237;guez, S Rodr&#237;guez, J P&#233;rez, SR Green, S Mai, N Rosen, C Hudis, J Baselga; citation_volume=108; citation_publication_date=2011; citation_pages=3761-3766; citation_doi=10.1073/pnas.1014835108; citation_id=CR38_3001">

    <meta name="citation_author" content="Lee, Yi Fang">

    <meta name="citation_author_institution" content="Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, Kragujevac, Singapore">

    <meta name="citation_author" content="Miller, Lance David">

    <meta name="citation_author_institution" content="Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, USA">

    <meta name="citation_author" content="Chan, Xiu Bin">

    <meta name="citation_author_institution" content="Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, Kragujevac, Singapore">

    <meta name="citation_author" content="Black, Michael A">

    <meta name="citation_author_institution" content="Department of Biochemistry, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand">

    <meta name="citation_author" content="Pang, Brendan">

    <meta name="citation_author_institution" content="Department of Pathology, National University Health System and National University of Singapore, Kragujevac, Singapore">

    <meta name="citation_author" content="Ong, Chee Wee">

    <meta name="citation_author_institution" content="Department of Pathology, National University Health System and National University of Singapore, Kragujevac, Singapore">

    <meta name="citation_author" content="Salto-Tellez, Manuel">

    <meta name="citation_author_institution" content="Centre for Cancer Research and Cell Biology, Queen&#8217;s University Belfast, Belfast, UK">

    <meta name="citation_author_institution" content="Cancer Science Institute, National University of Singapore, Kragujevac, Singapore">

    <meta name="citation_author" content="Liu, Edison T">

    <meta name="citation_author_institution" content="Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, Kragujevac, Singapore">

    <meta name="citation_author_institution" content="The Jackson Laboratory, Bar Harbor, USA">

    <meta name="citation_author" content="Desai, Kartiki V">

    <meta name="citation_author_institution" content="National Institute of Biomedical Genomics, Kalyani, India">



        <meta name="format-detection" content="telephone=no">

        
<link rel="apple-touch-icon" sizes="180x180" href=/static/img/favicons/bmc/apple-touch-icon-582ef1d0f5.png>
<link rel="icon" type="image/png" sizes="32x32" href=/static/img/favicons/bmc/favicon-32x32-5d7879efe1.png>
<link rel="icon" type="image/png" sizes="16x16" href=/static/img/favicons/bmc/favicon-16x16-c241ac1a2f.png>
<link rel="manifest" href=/static/app-bmc/manifest-3bb9ad383b.json>
<link rel="mask-icon" href=/static/img/favicons/bmc/safari-pinned-tab-427338756f.svg color="#e6e6e6">
<link rel="shortcut icon" data-test="shortcut-icon" href=/static/img/favicons/bmc/favicon-1886637b78.ico>
<meta name="msapplication-config" content=/static/app-bmc/browserconfig-ecd9aa8205.xml>
<meta name="msapplication-TileColor"
      content="#1b3051">
<meta name="msapplication-TileImage"
      content=/static/img/favicons/bmc/app-icon-144x144.png>
<meta name="theme-color"
      content="#1b3051">


        
        <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>

        


    
        <link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-article-cd4a428820.css>
    

    <link rel="stylesheet" media="screen" href=/static/app-bmc/css/core-b076aec3c2.css>
    <link rel="stylesheet" media="print" href=/static/app-bmc/css/print-b8af42253b.css>
    

    

    
        <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;font-size:1.8em;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em}p:last-child{margin-bottom:0}p:empty{display:none}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:"";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:"";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px;text-decoration:none}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container{-webkit-box-align:center;-webkit-box-pack:justify;align-items:center;display:flex;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-header__brand{margin-right:48px}.c-header__brand a,.c-journal-title a{text-decoration:none}.c-header__menu,.c-header__navigation{display:flex}.c-header__navigation{-webkit-box-align:center;align-items:center}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff;margin-right:24px}.c-header__item:last-child{margin-right:0}.c-header__link{color:#fff;text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{-webkit-box-pack:justify;display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#0097ef;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{-webkit-box-flex:0;align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{-webkit-box-align:baseline;align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.42857;padding:16px 0}.c-navbar__container{-webkit-box-pack:justify;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__container,.c-navbar__content{-webkit-box-align:center;align-items:center;display:flex}.c-navbar__content{-webkit-box-flex:0;flex:0 1 auto}@media only screen and (min-width:1024px){.c-navbar__content{display:flex!important}}.c-navbar__nav{display:flex;list-style:none;margin:0;padding:0}@media only screen and (min-width:1024px){.c-navbar__nav{transform:translateY(1px)}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{-webkit-box-align:center;-webkit-box-pack:center;align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg{fill:currentcolor}.u-button{color:#004b83}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{-webkit-box-align:center;align-items:center}.u-flex-static{-webkit-box-flex:0;flex:0 1 auto;flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:18px;font-style:normal;line-height:1.4;margin-bottom:.7em}.u-h4{font-style:italic;font-weight:700}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}body{font-size:1.125rem} }</style>

        <link rel="stylesheet" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-2b5751e1cf.css"
              media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">

        <style>@media only screen and (-webkit-min-device-pixel-ratio: 0) and (min-color-index: 0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio: 0) and (min-resolution: 3 e1dpcm) { .c-reading-companion__figure-title,.u-h3,.u-h4{font-family:Georgia,Palatino,serif;font-style:normal;line-height:1.4}.u-h3{margin-bottom:1em}.u-h4{margin-bottom:1em}button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;font-size:1.8em;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em;overflow-wrap:break-word;word-break:break-word}p:last-child{margin-bottom:0}p:empty{display:none}.u-h3{font-size:1.75rem;font-size:1.5rem;font-weight:700}.c-reading-companion__figure-title{font-size:1.25rem;font-weight:700}.u-h4{font-size:1.25rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-identifiers__open{color:#cc4b14}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{margin-left:0}.c-article-author-list li,.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list__item svg{margin-left:4px}.c-article-author-list__show-more{margin-right:4px}@media only screen and (max-width:539px){html.js .js-small-screen-show-inline{display:inline!important;visibility:visible!important}.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-button-author-list svg{margin:1px 4px 0 0}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{-webkit-box-align:baseline;align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;line-height:1.3;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:0 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-reading-companion__figure-full-link svg{margin-left:4px}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;display:inline-block;font-size:.875rem;font-weight:700;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#0067c5;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title,.c-nature-box{line-height:1.3}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-reading-companion{clear:both}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{-webkit-box-orient:horizontal;-webkit-box-direction:normal;display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{-webkit-box-flex:1;flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__figures-list,.c-reading-companion__references-list,.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1em;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{-webkit-box-pack:justify;display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{display:inline-block}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-article-associated-content__container .c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-reading-companion__panel--active{display:block}.c-pdf-download{display:flex;margin-bottom:24px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{-webkit-box-pack:justify;-webkit-box-flex:1;background:#173962;border:1px solid transparent;border-radius:2px;color:#fff;display:flex;flex:1 1 0%;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:space-between;line-height:1.3;padding:13px 24px;text-decoration:none}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}@media only screen and (max-width:30em){.js .js-smaller-author-etal{display:none;visibility:hidden}}.c-article-associated-content__container a{text-decoration:underline}.c-article-associated-content__container .c-article-associated-content__collection.collection~.c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__title{display:none}.c-article-associated-content__container .c-article-associated-content__collection.collection,.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.collection{margin-top:28px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.c-article-main-column .c-pdf-download{display:none}@media only screen and (max-width:1023px){.c-article-main-column .c-pdf-download{display:block}}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif} }</style>
        <link rel="stylesheet" data-inline-css-source="critical-css" href="/static/app-bmc/css/enhanced-article-415bd1e493.css"
              media="print" onload="this.media='only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)';this.onload=null">
    



        

        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: 'breast-cancer-research.biomedcentral.com',
            siteWithPath: 'breast-cancer-research.biomedcentral.com' + window.location.pathname,
            twitterHashtag: '',
            cmsPrefix: 'https://studio-cms.springernature.com/studio/',
            
            doi: '10.1186/bcr3200',
            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',
            hasFigshareInvoked: false,
            publisherBrand: 'BioMed Central',
            mustardcut: false
        };
    </script>

        
    <script type="text/javascript" data-test="dataLayer">
        window.dataLayer = [{"content":{"article":{"doi":"10.1186/bcr3200","articleType":"Research article","peerReviewType":"Closed","supplement":null,"keywords":"Breast Cancer;Ingenuity Pathway Analysis;Intrinsic Subtype;Dulbecco Modify Eagle Medium;Smad Phosphorylation"},"contentInfo":{"imprint":"BioMed Central","title":"JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer","publishedAt":1337731200000,"publishedAtDate":"2012-05-23","author":["Yi Fang Lee","Lance David Miller","Xiu Bin Chan","Michael A Black","Brendan Pang","Chee Wee Ong","Manuel Salto-Tellez","Edison T Liu","Kartiki V Desai"],"collection":[]},"attributes":{"deliveryPlatform":"oscar","template":"rebrand","cms":null,"copyright":{"creativeCommonsType":null,"openAccess":false},"environment":"live"},"journal":{"siteKey":"breast-cancer-research.biomedcentral.com","volume":"14","issue":"3","title":"Breast Cancer Research","type":"BioMed","journalID":13058,"section":[]},"category":{"pmc":{"primarySubject":"Biomedicine"},"contentType":"Research article","publishingSegment":"BioMed2"}},"session":{"authentication":{"authenticationID":[]}},"version":"1.0.0","page":{"category":{"pageType":"article"},"attributes":{"featureFlags":[],"environment":"live"}},"event":"dataLayerCreated"}];
    </script>

        

        
            <script>
                window.dataLayer.push({
                    cmpAndNewGtmFeatureFlag: true
                });
            </script>
        

        
        
            <script>
                window.dataLayer.push({
                    ga4MeasurementId: 'G-PJCTJWPV25',
                    ga360TrackingId: 'UA-54492316-9',
                    twitterId: 'o47a2',
                    ga4ServerUrl: 'https://collect.biomedcentral.com',
                    imprint: 'biomedcentral'
                });
            </script>
        
        

        
    <script>
        (function(w, d) {
            w.config = w.config || {};
            w.config.mustardcut = false;

            
            if (w.matchMedia && w.matchMedia('only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)').matches) {
                w.config.mustardcut = true;
                d.classList.add('js');
                d.classList.remove('grade-c');
            }
        })(window, document.documentElement);
    </script>



        
<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>

        
    <script class="js-entry">
        if (window.config.mustardcut) {
            (function(w, d) {
                
                
                
                    window.Component = {};
                    window.suppressShareButton = true;
                

                var currentScript = d.currentScript || d.head.querySelector('script.js-entry');

                
                function catchNoModuleSupport() {
                    var scriptEl = d.createElement('script');
                    return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)
                }

                var headScripts = [
                    {'src': '/static/js/polyfill-es5-bundle-95f6277fcf.js', 'async': false},
                    {'src': '/static/js/airbrake-es5-bundle-80569d2d62.js', 'async': false},
                ];

                var bodyScripts = [
                    {'src': '/static/js/app-es5-bundle-5306b345a4.js', 'async': false, 'module': false},
                    {'src': '/static/js/app-es6-bundle-8425be8e90.js', 'async': false, 'module': true}
                    
                    
                        , {'src': '/static/js/global-article-es5-bundle-d18afc649a.js', 'async': false, 'module': false},
                        {'src': '/static/js/global-article-es6-bundle-cef3b249aa.js', 'async': false, 'module': true}
                    
                ];

                function createScript(script) {
                    var scriptEl = d.createElement('script');
                    scriptEl.src = script.src;
                    scriptEl.async = script.async;
                    if (script.module === true) {
                        scriptEl.type = "module";
                        if (catchNoModuleSupport()) {
                            scriptEl.src = '';
                        }
                    } else if (script.module === false) {
                        scriptEl.setAttribute('nomodule', true)
                    }
                    if (script.charset) {
                        scriptEl.setAttribute('charset', script.charset);
                    }

                    return scriptEl;
                }

                for (var i = 0; i < headScripts.length; ++i) {
                    var scriptEl = createScript(headScripts[i]);
                    currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);
                }

                d.addEventListener('DOMContentLoaded', function() {
                    for (var i = 0; i < bodyScripts.length; ++i) {
                        var scriptEl = createScript(bodyScripts[i]);
                        d.body.appendChild(scriptEl);
                    }
                });

                // Webfont repeat view
                var config = w.config;
                if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {
                    d.documentElement.className += ' webfonts-loaded';
                }
            })(window, document);
        }
    </script>




        
            
            
                <script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                
                    j.src = 'https://collect.biomedcentral.com/gtm.js?id=' + i + dl;
                
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>

            
            
        

        <script>
    (function (w, d, t) {
        function cc() {
            var h = w.location.hostname;
            var e = d.createElement(t),
            s = d.getElementsByTagName(t)[0];

            if (h.indexOf('springer.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-17-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else if (h.indexOf('biomedcentral.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-15-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else if (h.indexOf('springeropen.com') > -1) {
                e.src = 'https://push-content.springernature.io/pcf_sb_5_1617714720898560639/production_live/consent-bundle-16-9.js';
                e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-444fb65518.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window, document, 'script');
</script>


        
    
        
    


        
    
    <link rel="canonical" href="//breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3200"/>
    

        
        
        
        <meta property="og:url" content="https://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr3200">
        <meta property="og:type" content="article">
        <meta property="og:site_name" content="BioMed Central">
        <meta property="og:title" content="JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer - Breast Cancer Research">
        <meta property="og:description" content="Introduction We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer. Methods Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. JMJD6 emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-based assays elucidated molecular mechanisms of JMJD6 action in breast cancer progression and shed light on the clinical breast cancer subtypes relevant to JMJD6 action. Results JMJD6 was expressed at highest levels in tumors associated with worse outcomes, including ER- and basal-like, Claudin-low, Her2-enriched, and ER+ Luminal B tumors. High nuclear JMJD6 protein was associated with ER negativity, advanced grade, and poor differentiation in tissue microarrays. Separation of ER+/LN- patients that received endocrine monotherapy indicated that JMJD6 is predictive of poor outcome in treatment-specific subgroups. In breast cancer cell lines, loss of JMJD6 consistently resulted in suppressed proliferation but not apoptosis, whereas forced stable overexpression increased growth. In addition, knockdown of JMJD6 in invasive cell lines, such as MDA-MB231, decreased motility and invasion, whereas overexpression in MCF-7 cells slightly promoted motility but did not confer invasive growth. Microarray analysis showed that the most significant transcriptional changes occurred in cell-proliferation genes and genes of the TGF- tumor-suppressor pathway. High proliferation was characterized by constitutively high cyclin E protein levels. The inverse relation of JMJD6 expression with TGF- 2 could be extrapolated to the breast cancer cohorts, suggesting that JMJD6 may affect similar pathways in primary breast cancer. Conclusions JMJD6 is a novel biomarker of tumor aggressiveness with functional implications in breast cancer growth and migration.">
        <meta property="og:image" content="https://media.springernature.com/w200/springer-static/cover/journal/13058.jpg">
    
        

        
    <script type="application/ld+json">{"mainEntity":{"headline":"JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer","description":"We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer. Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. JMJD6 emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-based assays elucidated molecular mechanisms of JMJD6 action in breast cancer progression and shed light on the clinical breast cancer subtypes relevant to JMJD6 action. \nJMJD6 was expressed at highest levels in tumors associated with worse outcomes, including ER- and basal-like, Claudin-low, Her2-enriched, and ER+ Luminal B tumors. High nuclear JMJD6 protein was associated with ER negativity, advanced grade, and poor differentiation in tissue microarrays. Separation of ER+/LN- patients that received endocrine monotherapy indicated that JMJD6 is predictive of poor outcome in treatment-specific subgroups. In breast cancer cell lines, loss of JMJD6 consistently resulted in suppressed proliferation but not apoptosis, whereas forced stable overexpression increased growth. In addition, knockdown of JMJD6 in invasive cell lines, such as MDA-MB231, decreased motility and invasion, whereas overexpression in MCF-7 cells slightly promoted motility but did not confer invasive growth. Microarray analysis showed that the most significant transcriptional changes occurred in cell-proliferation genes and genes of the TGF- tumor-suppressor pathway. High proliferation was characterized by constitutively high cyclin E protein levels. The inverse relation of JMJD6 expression with TGF-\n\n                    2\n                   could be extrapolated to the breast cancer cohorts, suggesting that JMJD6 may affect similar pathways in primary breast cancer. \nJMJD6 is a novel biomarker of tumor aggressiveness with functional implications in breast cancer growth and migration.","datePublished":"2012-05-23","dateModified":"2012-05-23","pageStart":"1","pageEnd":"16","sameAs":"https://doi.org/10.1186/bcr3200","keywords":"Cancer Research,Oncology,Surgical Oncology","image":"https://static-content.springer.com/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig1_HTML.jpg","isPartOf":{"name":"Breast Cancer Research","issn":["1465-542X"],"volumeNumber":"14","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"BioMed Central","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Lee, Yi Fang","affiliation":[{"name":"Genome Institute of Singapore","address":{"name":"Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, Kragujevac, Singapore","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Miller, Lance David","affiliation":[{"name":"Wake Forest University School of Medicine","address":{"name":"Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Chan, Xiu Bin","affiliation":[{"name":"Genome Institute of Singapore","address":{"name":"Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, Kragujevac, Singapore","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Black, Michael A","affiliation":[{"name":"University of Otago","address":{"name":"Department of Biochemistry, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Pang, Brendan","affiliation":[{"name":"National University Health System and National University of Singapore","address":{"name":"Department of Pathology, National University Health System and National University of Singapore, Kragujevac, Singapore","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ong, Chee Wee","affiliation":[{"name":"National University Health System and National University of Singapore","address":{"name":"Department of Pathology, National University Health System and National University of Singapore, Kragujevac, Singapore","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Salto-Tellez, Manuel","affiliation":[{"name":"Queens University Belfast","address":{"name":"Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, UK","@type":"PostalAddress"},"@type":"Organization"},{"name":"Cancer Science Institute, National University of Singapore","address":{"name":"Cancer Science Institute, National University of Singapore, Kragujevac, Singapore","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Liu, Edison T","affiliation":[{"name":"Genome Institute of Singapore","address":{"name":"Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, Kragujevac, Singapore","@type":"PostalAddress"},"@type":"Organization"},{"name":"The Jackson Laboratory","address":{"name":"The Jackson Laboratory, Bar Harbor, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Desai, Kartiki V","affiliation":[{"name":"National Institute of Biomedical Genomics","address":{"name":"National Institute of Biomedical Genomics, Kalyani, India","@type":"PostalAddress"},"@type":"Organization"}],"email":"kd1@nibmg.ac.in","@type":"Person"}],"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>

        
    </head>

    <body class="journal journal-fulltext"
    
          >
        
    
        
            <!-- Google Tag Manager (noscript) -->
            <noscript>
                <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                        height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
            <!-- End Google Tag Manager (noscript) -->
        
    

        <div class="u-visually-hidden" aria-hidden="true">
    
    <?xml version="1.0" encoding="UTF-8"?><!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"/></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"/></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"/></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"/></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"/></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"/></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"/></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"/></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"/></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"/></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"/></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"/></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"/></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"/></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"/></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"/></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"/></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"/></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"/></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"/></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"/></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"/></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"/></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m1.00087166 7h5.99912834v-5.99912834c0-.55276615.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v5.99912834h5.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-5.9991283v5.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-5.9991283h-5.99912834c-.55276615 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"/></symbol><symbol id="icon-search"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"/></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"/></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"/></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"/></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"/></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"/></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"/></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"/></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"/></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"/></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"/></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/><path d="M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213
	c-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354
	L483.025,280.48L483.025,280.48z"/></symbol><symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"><g><path d="M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502
		c-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71
		c0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361
		c0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656
		c-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883
		c-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215
		c4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z"/></g><path d="M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z"/></symbol><symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z
	 M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z"/><g><path d="M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588
		c2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63
		c-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021
		c0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027
		c-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493
		C485.697,280.594,484.689,279.911,483.782,279.63"/><path d="M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72
		c0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0
		c-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833
		"/><path d="M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621
		c0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0
		c-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276"/><path d="M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389
		c0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301
		c-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393
		C477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396
		c-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437"/></g></symbol><symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"/></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 3)"/></symbol><symbol id="icon-download-rounded"><path d="M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z"/></symbol><symbol id="icon-ext-link" viewBox="0 0 16 16"><path d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"/><path d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"/><path d="M9.7 0L16 6.2V0z"/></symbol><symbol id="icon-remove" viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"/><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"/></symbol><symbol id="icon-rss" viewBox="0 0 18 18"><path d="m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z" fill-rule="evenodd"/></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/></symbol><symbol id="icon-springer-collections" viewBox="3 3 32 32"><path fill-rule="evenodd" d="M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z"/></symbol><symbol id="icon-springer-download" viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"/></symbol><symbol id="icon-springer-info" viewBox="0 0 24 24"><!--Generator: Sketch 63.1 (92452) - https://sketch.com--><g id="V&amp;I" stroke="none" stroke-width="1" fill-rule="evenodd"><g id="info" fill-rule="nonzero"><path d="M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z" id="Combined-Shape"/></g></g></symbol><symbol id="icon-springer-tick-circle" viewBox="0 0 24 24"><g id="Page-1" stroke="none" stroke-width="1" fill-rule="evenodd"><g id="springer-tick-circle" fill-rule="nonzero"><path d="M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z" id="path-1"/></g></g></symbol><symbol id="icon-updates" viewBox="0 0 18 18"><g fill-rule="nonzero"><path d="M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z"/><path d="M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z"/></g></symbol></svg>
</div>


        

        

    <div class="u-vh-full">
        <a class="c-skip-link" href="#main-content">Skip to main content</a>
        
            
    
        <div class="u-hide u-show-following-ad"></div>
    
    <aside class="adsbox c-ad c-ad--728x90" data-component-mpu>
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-LB1"
                data-ad-type="LB1"
                data-pa11y-ignore
                data-gpt
                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"
                data-gpt-sizes="728x90,970x90"
                data-gpt-targeting="pos=LB1;doi=10.1186/bcr3200;type=article;kwrd=Breast Cancer,Ingenuity Pathway Analysis,Intrinsic Subtype,Dulbecco Modify Eagle Medium,Smad Phosphorylation;pmc=B11001,H33160,H59150;"
            >
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/bcr3200&amp;type=article&amp;kwrd=Breast Cancer,Ingenuity Pathway Analysis,Intrinsic Subtype,Dulbecco Modify Eagle Medium,Smad Phosphorylation&amp;pmc=B11001,H33160,H59150&amp;">
                        <img data-test="gpt-advert-fallback-img"
                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/bcr3200&amp;type=article&amp;kwrd=Breast Cancer,Ingenuity Pathway Analysis,Intrinsic Subtype,Dulbecco Modify Eagle Medium,Smad Phosphorylation&amp;pmc=B11001,H33160,H59150&amp;"
                            alt="Advertisement"
                            width="728"
                            height="90">
                    </a>
                </noscript>
            </div>
        </div>
    </aside>

        
        

         
    
        <div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"></div>
    
    
        <div id="top" class="u-position-relative">
    <header class="c-header" data-test="publisher-header">
        <div class="c-header__container">
            <div class="c-header__brand u-mr-48" itemscope itemtype="http://schema.org/Organization" data-test="navbar-logo-header">
                <div class="c-logo">
    <a href="https://www.biomedcentral.com" itemprop="url">
        <img alt="BMC" itemprop="logo" width="76" height="18" role="img" src=/static/images/bmc/logos/logo-bmc-white-aj-be532aa3f0.svg>
        <div class="c-logo__strapline">
            <img alt="Part of Springer Nature" width="173" height="16" role="img" src=/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg>
        </div>
    </a>
</div>

            </div>
            <div class="c-header__navigation">
                <button
                    type="button"
                    class="c-header__link u-button-reset u-mr-24"
                    data-expander
                    data-expander-target="#publisher-header-search"
                    data-expander-autofocus="firstTabbable"
                    data-test="header-search-button"
                    aria-controls="publisher-header-search"
                    aria-expanded="false">
                    <span class="u-display-flex u-align-items-center">
                        <span class="u-text-sm">Search</span>
                        <svg class="u-icon u-flex-static u-ml-8" aria-hidden="true" focusable="false">
                            <use xlink:href="#global-icon-search"></use>
                        </svg>
                    </span>
                </button>
                <nav>
                    <ul class="c-header__menu" data-enhanced-menu data-test="publisher-navigation">
                        
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/journals">
                                        Explore journals
                                    </a>
                                </li>
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/getpublished">
                                        Get published
                                    </a>
                                </li>
                            
                                <li class="c-header__item u-hide-at-lt-lg">
                                    <a class="c-header__link"
                                       href="//www.biomedcentral.com/about">
                                        About BMC
                                    </a>
                                </li>
                            
                        
                        <li class="c-header__item">
                            <a data-enhanced-account
                               class="c-header__link"
                               href="https://www.biomedcentral.com/account"
                               data-test="login-link">
                                My account
                            </a>
                        </li>
                    </ul>
                </nav>
            </div>
        </div>
    </header>
    <div class="c-popup-search u-js-hide" id="publisher-header-search">
        <div class="u-container">
            <div class="c-popup-search__container">
                <div class="ctx-search">
    <form role="search" class="c-form-field" method="GET" action="//www.biomedcentral.com/search" data-track="submit"
        data-track-category="Search and Results" data-track-action="Submit search" data-dynamic-track-label data-track-label="" data-test="global-search">
        <label for="publisherSearch" class="c-form-field__label">Search all BMC articles</label>
        <div class="u-display-flex">
            <input id="publisherSearch" class="c-form-field__input" data-search-input autocomplete="off" role="textbox" data-test="search-input" name="query" type="text" value=""/>
            <div>
                <button class="u-button" type="submit" data-test="search-submit-button">
    <span class="u-visually-hidden">Search</span>
    <svg class="u-icon u-flex-static" width="16" height="16" aria-hidden="true" focusable="false">
        <use xlink:href="#global-icon-search"></use>
    </svg>
</button>


            </div>
        </div>
        <input type="hidden" name="searchType" value="publisherSearch"/>
    </form>
</div>

            </div>
        </div>
    </div>
</div>

    

        
            <header class="c-journal-header c-journal-header--breast-cancer-research ctx-journal-header">
                <div class="u-container">
                    <div class="c-journal-header__inner ">
                        
                        <div class="c-journal-title" id="journalTitle">
                            <a href="/">
    
        
    
    <span class="c-journal-title__text ">Breast Cancer Research</span>
    
</a>
                        </div>
                        
                    </div>
                </div>
                <div class="c-navbar">
                    <div class="c-navbar__container">
                        
                            <div class="c-navbar__content">
                                <nav class="c-navbar__nav">
                                    <ul class="c-navbar__nav c-navbar__nav--journal" role="menu" data-test="site-navigation">
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="Home" data-track-action="Clicked journal navigation link" href='/'>Home</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="About" data-track-action="Clicked journal navigation link" href='/about'>About</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link c-navbar__link--is-shown" data-track="click" data-track-category="Articles" data-track-action="Clicked journal navigation link" href='/articles'>Articles</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" data-track="click" data-track-category="Submission Guidelines" data-track-action="Clicked journal navigation link" href='/submission-guidelines'>Submission Guidelines</a>
                                            </li>
                                        
                                    </ul>
                                </nav>
                            </div>
                        
                    </div>
                </div>
                <div class="c-journal-header__identity c-journal-header__identity--midnight-purple">
                    
                </div>
            </header>
            
        

        <div class="u-container u-mt-32 u-mb-32 u-clearfix" id="main-content" data-component="article-container">

            <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
                
    <div class="c-pdf-download u-clear-both">
        <a href="//breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3200.pdf" class="c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>

                <article lang="en">
                    <div class="c-article-header">
                        
    


                        <ul class="c-article-identifiers" data-test="article-identifier">
                            
    
        <li class="c-article-identifiers__item" data-test="article-category">Research article</li>
    
    
        <li class="c-article-identifiers__item">
            <span class="c-article-identifiers__open" data-test="open-access">Open Access</span>
        </li>
    
    

                            <li class="c-article-identifiers__item"><a href="#article-info" data-track="click" data-track-action="publication date" data-track-label="link">Published: <time datetime="2012-05-23">23 May 2012</time></a></li>
                        </ul>

                        <h1 class="c-article-title" data-test="article-title" data-article-title="">JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer</h1>
                        <ul class="c-article-author-list js-etal-collapsed" data-etal="25" data-etal-small="3" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Yi_Fang-Lee" data-author-popup="auth-Yi_Fang-Lee">Yi Fang Lee</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Lance_David-Miller" data-author-popup="auth-Lance_David-Miller">Lance David Miller</a><sup class="u-js-hide"><a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Xiu_Bin-Chan" data-author-popup="auth-Xiu_Bin-Chan">Xiu Bin Chan</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Michael_A-Black" data-author-popup="auth-Michael_A-Black">Michael A Black</a><sup class="u-js-hide"><a href="#Aff6">6</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Brendan-Pang" data-author-popup="auth-Brendan-Pang">Brendan Pang</a><sup class="u-js-hide"><a href="#Aff3">3</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Chee_Wee-Ong" data-author-popup="auth-Chee_Wee-Ong">Chee Wee Ong</a><sup class="u-js-hide"><a href="#Aff3">3</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Manuel-Salto_Tellez" data-author-popup="auth-Manuel-Salto_Tellez">Manuel Salto-Tellez</a><sup class="u-js-hide"><a href="#Aff4">4</a>,<a href="#Aff5">5</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Edison_T-Liu" data-author-popup="auth-Edison_T-Liu">Edison T Liu</a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff7">7</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Kartiki_V-Desai" data-author-popup="auth-Kartiki_V-Desai" data-corresp-id="c1">Kartiki V Desai<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-email"></use></svg></a><sup class="u-js-hide"><a href="#Aff8">8</a></sup></li></ul>
                        <p class="c-article-info-details" data-container-section="info">
                            
    <a data-test="journal-link" href="/"><i data-test="journal-title">Breast Cancer Research</i></a>

                            <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>14</b>, Articlenumber:<span data-test="article-number">3001</span> (<span data-test="article-publication-year">2012</span>)
            <a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                        </p>
                        
    <div class="c-article-metrics-bar__wrapper u-clear-both">
        <ul class="c-article-metrics-bar u-list-reset">
            
                <li class=" c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">9434 <span class="c-article-metrics-bar__label">Accesses</span></p>
                </li>
            
            
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__count">65 <span class="c-article-metrics-bar__label">Citations</span></p>
                </li>
            
            
                
                    <li class="c-article-metrics-bar__item">
                        <p class="c-article-metrics-bar__count">3 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                    </li>
                
            
            <li class="c-article-metrics-bar__item">
                <p class="c-article-metrics-bar__details"><a href="/articles/10.1186/bcr3200/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
            </li>
        </ul>
    </div>

                        
                        
    
        <div class="u-mb-8 c-status-message c-status-message--boxed c-status-message--info">
            <span class="c-status-message__icon">
                <svg class="u-icon" width="18" height="18" aria-hidden="true" focusable="false">
                    <use xlink:href="#icon-info"></use>
                </svg>
            </span>
            
                
                    <p>An <a href="/articles/10.1186/s13058-017-0830-9" class="relation-link" data-track="click" data-track-action="view linked article" data-track-label="link">Erratum</a> to this article was published on 28 March 2017</p>
                
            
        </div>
    

    

                        
                    </div>

                    <section aria-labelledby="Abs1_3001" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1_3001">Abstract</h2><div class="c-article-section__content" id="Abs1_3001-content"><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Introduction</h3><p>We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Methods</h3><p>Through microarray informatics, Cox proportional hazards regression was used to analyze the correlation between gene expression and distant metastasis-free survival (DMFS) of patients in 14 independent breast cancer cohorts. <i>JMJD6</i> emerged as a top candidate gene robustly associated with poor patient survival. Immunohistochemistry, siRNA-mediated silencing, and forced overexpression of JMJD6 in cell-based assays elucidated molecular mechanisms of JMJD6 action in breast cancer progression and shed light on the clinical breast cancer subtypes relevant to JMJD6 action.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Results</h3><p>
<i>JMJD6</i> was expressed at highest levels in tumors associated with worse outcomes, including ER- and basal-like, Claudin-low, Her2-enriched, and ER<sup>+</sup> Luminal B tumors. High nuclear JMJD6 protein was associated with ER negativity, advanced grade, and poor differentiation in tissue microarrays. Separation of ER<sup>+</sup>/LN<sup>-</sup> patients that received endocrine monotherapy indicated that <i>JMJD6</i> is predictive of poor outcome in treatment-specific subgroups. In breast cancer cell lines, loss of <i>JMJD6</i> consistently resulted in suppressed proliferation but not apoptosis, whereas forced stable overexpression increased growth. In addition, knockdown of <i>JMJD6</i> in invasive cell lines, such as MDA-MB231, decreased motility and invasion, whereas overexpression in MCF-7 cells slightly promoted motility but did not confer invasive growth. Microarray analysis showed that the most significant transcriptional changes occurred in cell-proliferation genes and genes of the TGF- tumor-suppressor pathway. High proliferation was characterized by constitutively high cyclin E protein levels. The inverse relation of <i>JMJD6</i> expression with <i>TGF-</i>
<sub>
                    <i>2</i>
                  </sub> could be extrapolated to the breast cancer cohorts, suggesting that <i>JMJD6</i> may affect similar pathways in primary breast cancer.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Conclusions</h3><p>
<i>JMJD6</i> is a novel biomarker of tumor aggressiveness with functional implications in breast cancer growth and migration.</p></div></div></section>
                    
    


                    <section data-title="Introduction"><div class="c-article-section" id="Sec1_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1_3001">Introduction</h2><div class="c-article-section__content" id="Sec1_3001-content"><p>In breast cancer, resistance to standard-of-care systemic adjuvant treatments such as endocrine and chemotherapies remains a major health burden and prompts the need for novel therapeutic targets for patients with advanced, unresponsive, or relapsed disease. We previously used gene-expression profiles of breast tumors to identify extracellular/secretory proteins and cell surface-receptor genes whose high expression levels associate with poor clinical end points. For example, we recently identified serine protease inhibitor Kazal-type 1 (<i>SPINK1</i>) as an important therapeutic target in breast cancer by using a combined genotype and phenotype screening approach. We found that inhibition of SPINK1 by neutralizing antibodies curtailed multiple aggressive properties, including cell survival, invasiveness, and chemoresistance [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Soon WWML, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai K, Liu ET: Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.&#xA;EMBO Mol Med 2011, 3:451464." href="/articles/10.1186/bcr3200#ref-CR1_3001" id="ref-link-section-d167701133e877">1</a>]. A second candidate identified in the same study was the phosphatidylserine receptor (<i>PTDSR</i>).</p><p>Formerly, PTDSR was thought to be a cell-surface protein that facilitates recruitment of phagocytic cells to sites of apoptosis. Antibodies against PTDSR and annexin V have been used in combination to estimate apoptosis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells.&#xA;Nature 2000, 405:8590." href="/articles/10.1186/bcr3200#ref-CR2_3001" id="ref-link-section-d167701133e886">2</a>]. Mouse knockouts of PTDSR showed early postnatal lethality and had growth retardation and multiple developmental abnormalities due to insufficient differentiation during embryogenesis; however, no defect in apoptotic clearance of cells was evident [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Bose J, Gruber A, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A: The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal.&#xA;J Biol 2004, 3:15." href="/articles/10.1186/bcr3200#ref-CR3_3001" id="ref-link-section-d167701133e889">3</a>]. By generation of deletion mutants and immune localization, Cui <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Cui P, Qin B, Liu N, Pan G, Pei D: Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals.&#xA;Exp Cell Res 2004, 293:154163." href="/articles/10.1186/bcr3200#ref-CR4_3001" id="ref-link-section-d167701133e895">4</a>] demonstrated that PTDSR is a nuclear protein, with five nuclear localization signals scattered throughout its sequence. Later, PTDSR was renamed Jumonji domain containing 6 (<i>JMJD6</i>) based on the presence of its JMJC domain with bifunctional histone arginine demethylation and lysyl oxidase activity [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Cui P, Qin B, Liu N, Pan G, Pei D: Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals.&#xA;Exp Cell Res 2004, 293:154163." href="/articles/10.1186/bcr3200#ref-CR4_3001" id="ref-link-section-d167701133e902">4</a><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B, Nielsen ML, Schmitz C, Butler DS, Yates JR, Delahunty CM, Hahn P, Lengeling A, Mann M, Proudfoot NJ, Schofield CJ, Bttger A: Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.&#xA;Science 2009, 325:9093." href="/articles/10.1186/bcr3200#ref-CR6_3001" id="ref-link-section-d167701133e905">6</a>]. JMJD6 is homologous to the hypoxia-inducible factor (HIF) asparaginyl-hydroxylase, suggesting a function in cellular response to hypoxia. In addition, JMJD6 protein was recently shown to interact with splicing factor U2AF65; however, very few splicing events in a limited number of genes were attributable to <i>JMJD6</i> expression [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B, Nielsen ML, Schmitz C, Butler DS, Yates JR, Delahunty CM, Hahn P, Lengeling A, Mann M, Proudfoot NJ, Schofield CJ, Bttger A: Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.&#xA;Science 2009, 325:9093." href="/articles/10.1186/bcr3200#ref-CR6_3001" id="ref-link-section-d167701133e911">6</a>]. In endothelial cells, alternate splicing of VEGF receptor (Flt1) by U2AF65 promoted endothelial cell migration, and siRNA-mediated knockdown of <i>JMJD6</i> in endothelial cells led to decreased migration [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Boeckel J-N, Guarani V, Koyanagi M, Roexe T, Lengeling A, Schermuly RT, Gellert P, Braun T, Zeiher A, Dimmeler S: Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1.&#xA;Proc Natl Acad Sci USA 2011, 108:32763281." href="/articles/10.1186/bcr3200#ref-CR7_3001" id="ref-link-section-d167701133e917">7</a>]. Based on X-ray crystallographic data, it was predicted and shown that apart from its enzymatic activity, JMJD6 protein bound single-stranded RNA [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Hong X, Zang J, White J, Wang C, Pan CH, Zhao R, Murphy RC, Dai S, Henson P, Kappler JW, Hagman J, Zhang G: Interaction of JMJD6 with single-stranded RNA.&#xA;Proc Natl Acad Sci USA 2010, 107:1456814572." href="/articles/10.1186/bcr3200#ref-CR8_3001" id="ref-link-section-d167701133e921">8</a>]. These diverse findings predict a range of versatile functions for JMJD6, at the transcriptional, splicing, posttranscriptional, and biochemical levels. However, very little is known about the role of JMJD6 in cancer and the molecular pathways that may impinge on disease initiation and prognosis.</p><p>Because our <i>in silico</i> analysis demonstrated a robust positive association between <i>JMJD6</i> expression and breast cancer recurrence, we investigated its phenotypic and molecular effects in breast cancer cells. We report herein that perturbation of <i>JMJD6</i> expression modulates cell proliferation and cell scattering and motility: phenotypes associated with cancer metastasis. Furthermore, our findings suggest that these cellular phenotypes may be elicited by JMJD6-mediated suppression of transforming growth factor-beta 2 (TGF-2) and/or activation of proteins that potentiate cell division in a cell type-specific manner. These <i>in vitro</i> mechanistic findings are consistent with the clinical observations that <i>JMJD6</i> expression correlates positively with proliferation index and high histologic grade but inversely with <i>TGF-2</i> expression. Together, these data implicate JMJD6 function in breast tumor progression and suggest a diagnostic role for JMJD6 in predicting patient outcomes.</p></div></div></section><section data-title="Materials and methods"><div class="c-article-section" id="Sec2_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2_3001">Materials and methods</h2><div class="c-article-section__content" id="Sec2_3001-content"><h3 class="c-article__sub-heading" id="Sec3_3001">Breast cancer clinical datasets</h3><p>Tumor-expression profiles were obtained with approval from and in accordance with the policies of the institutional review boards of the respective institutions. An integrated "Super Cohort" (SC) of 15 individual Affymetrix array datasets comprising 2,116 breast cancer patients was used in this analysis. These datasets were previously described in detail in Soon <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Soon WWML, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai K, Liu ET: Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.&#xA;EMBO Mol Med 2011, 3:451464." href="/articles/10.1186/bcr3200#ref-CR1_3001" id="ref-link-section-d167701133e961">1</a>]. These cohorts were accessible from public databases, Gene Expression Omnibus (National Center for Biotechnology Information, Bethesda, MD, USA), ArrayExpress (European Bioinformatics Institute, Hinxton, UK), and caArray (National Cancer Institute, NIH, Atlanta, GA, USA). Appropriate permission has been granted for the use of the datasets and corresponding de-identified clinical data. A summary of the clinical dataset details and literature references can be found in Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM1">1</a>, Table S1. Initial discovery and meta-analysis was performed on a subset of this Super Cohort.</p><p>All raw data (CEL files) were preprocessed and normalized by using the R software package [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Team RDC: R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. 2010." href="/articles/10.1186/bcr3200#ref-CR9_3001" id="ref-link-section-d167701133e970">9</a>], and library files provided via the Bioconductor [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics.&#xA;Genome Biol 2004, 5:R80." href="/articles/10.1186/bcr3200#ref-CR10_3001" id="ref-link-section-d167701133e973">10</a>]. Raw data were MAS5.0 normalized on a per-cohort basis by using the justMAS function in the simpleaffy library from Bioconductor (no background correction, target intensity of 600). Cross-cohort batch effects were corrected by using the COMBAT empirical Bayes method [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Li C, Rabinovic A: Adjusting batch effects in microarray expression data using empirical Bayes methods.&#xA;Biostatistics 2007, 8:118127." href="/articles/10.1186/bcr3200#ref-CR11_3001" id="ref-link-section-d167701133e976">11</a>]. Normalized <i>JMJD6</i> probesets, 212722_s_at and 212723_at, were averaged for the analysis of data from Affymetrix U133 arrays, and <i>JMJD6</i> probe, AB011157, was used for the analysis of the Agilent array dataset (that is, the NKI dataset). Of 2,116 array profiles in the Super Cohort, 1,954 patient cases are annotated with distant metastasis-free survival (DMFS) time and event information.</p><h3 class="c-article__sub-heading" id="Sec4_3001">Clinical survival analysis and expression in subtypes</h3><p>Distant metastasis-free survival (DMFS) was used as the clinical end point of interest. A DMFS event was defined as metastatic recurrence to a distant organ site or in a limited number of cases, as death owing to progressive breast cancer. Cox proportional hazard regression analysis of <i>JMJD6</i> expression with DMFS data (Time and Event) was performed in individual patient datasets and in the Super Cohort. Clinical subtype analysis was performed by using the Super Cohort. Intrinsic subtypes were assigned via the PAM50 algorithm of Parker <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS: Supervised risk predictor of breast cancer based on intrinsic subtypes.&#xA;J Clin Oncol 2009, 27:11601167." href="/articles/10.1186/bcr3200#ref-CR12_3001" id="ref-link-section-d167701133e999">12</a>], by using the code provided by the authors at UNC Microarray Database [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="&#xA;UNC Microarray Database&#xA;[&#xA;                    https://genome.unc.edu/pubsup/breastGEO&#xA;                    &#xA;                  ]" href="/articles/10.1186/bcr3200#ref-CR13_3001" id="ref-link-section-d167701133e1002">13</a>]. Gene data were matched by symbol and median centered, and Spearman correlation was used to assign samples to the nearest PAM50 centroid. Claudin-Low subtypes were assigned based on the method described by Prat <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Prat A, Parker J, Karginova O, Fan C, Livasy C, Herschkowitz J, He X, Perou C: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.&#xA;Breast Cancer Res 2010, 12:R68." href="/articles/10.1186/bcr3200#ref-CR14_3001" id="ref-link-section-d167701133e1009">14</a>], by using the microarray data (GSE18229) and information provided by the authors at UNC Microarray Database [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="&#xA;UNC Microarray Database&#xA;[&#xA;                    https://genome.unc.edu/pubsup/breastGEO&#xA;                    &#xA;                  ]" href="/articles/10.1186/bcr3200#ref-CR13_3001" id="ref-link-section-d167701133e1012">13</a>]. Claudin-Low and Normal centroids were generated, and samples were assigned to one or the other class based on euclidean distance to the class centroid. The PAM50 and Claudin-Low subtype information was then combined with the PAM50 subtype used, unless a sample had been classified as Claudin-Low, in which case, the Claudin-Low assignment would take precedence.</p><p>Distribution of <i>JMJD6</i> expression in various breast cancer subtypes was analyzed with the Kruskal-Wallis one-way analysis of variance (ANOVA) on ranks and multiple pairwise comparisons with the Dunn method by using Sigma Plot. Statistical significance of differential <i>JMJD6</i> expression in ER-positive versus ER-negative tumors was analyzed by using the Mann-Whitney Rank Sum Test. In Kaplan-Meier and CoxPH survival analysis of <i>JMJD6</i> expression cohorts in the clinical subtypes, the patients were separated by median expression across the Super Cohort into high and low <i>JMJD6</i>-expression groups. Kaplan-Meier survival analysis also was performed on patient groups ranked by quartile expression within each clinical subtype. All survival analyses were performed by using Sigma Plot [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="&#xA;SigmaPlot for Windows 11.0th edition. Systat Software, Inc., San Jose, CA; 2008." href="/articles/10.1186/bcr3200#ref-CR15_3001" id="ref-link-section-d167701133e1030">15</a>].</p><h3 class="c-article__sub-heading" id="Sec5_3001">Immunohistochemistry</h3><p>Tissue microarray (TMA) blocks containing cores from 98 breast cancer patients were constructed, as described previously, under institutional ethics committee approval with consent for the tissue microarray program (NUS-IRB 05-017) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Soon WWML, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai K, Liu ET: Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.&#xA;EMBO Mol Med 2011, 3:451464." href="/articles/10.1186/bcr3200#ref-CR1_3001" id="ref-link-section-d167701133e1041">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Salto-Tellez M, Nga ME, Han HC, Wong AS, Lee CK, Anuar D, Ng SS, Ho M, Wee A, Chan YH, Soong R: Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours.&#xA;Br J Cancer 2007, 96:776782." href="/articles/10.1186/bcr3200#ref-CR16_3001" id="ref-link-section-d167701133e1044">16</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Das K, Mohd Omar MF, Ong CW, Bin Abdul Rashid S, Peh BK, Putti TC, Tan PH, Chia KS, Teh M, Shah N, Soong R, Salto-Tellez M: TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.&#xA;Pathology 2008, 40:441449." href="/articles/10.1186/bcr3200#ref-CR17_3001" id="ref-link-section-d167701133e1047">17</a>] and used for the analysis. Anti-JMJD6 monoclonal antibody (Santa Cruz, Santa Cruz, CA, USA: Sc-28348) was used at a dilution of 1:50 along with antigen retrieval by heat and Tris-EDTA (pH 9.1). Automated IHC scoring was performed with the Ariol SL-50 image analysis system (Applied Imaging, Santa Clara, CA, USA). Positivity of JMJD6 nuclear expression was defined as nuclear-staining intensity and percentage coverage scores 25%. Odds-ratio analysis was performed on JMJD6-positive expression and clinicopathologic features of the tumors by using PASW Statistics 18 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="&#xA;PASW Statistics 18 18.0.0 edition. Chicago: SPSS Inc.; 2009." href="/articles/10.1186/bcr3200#ref-CR18_3001" id="ref-link-section-d167701133e1050">18</a>].</p><h3 class="c-article__sub-heading" id="Sec6_3001">Cell lines</h3><p>All cell lines were obtained from American Type Culture Collection (ATCC) and maintained in growth media, at 37C with 5% CO<sub>2</sub>. The growth medium for MCF-7, CAMA-1, and BT-549 was Dulbecco Modified Eagle Medium (DMEM), with 10% fetal bovine serum (FBS); and for MDA-MB231 and T47D, it was RPMI-1640, with 10% FBS.</p><h3 class="c-article__sub-heading" id="Sec7_3001">Cloning and expression of <i>JMJD6</i>
</h3><p>
<i>JMJD6</i> (NM_001081461.1) (J1) was amplified by using MCF-7 mRNA (forward primer: 5'CCCAAGCTTATGAACCACAAGAGCAAGAAG3'; reverse primer: 5' GCTCTAGATCACCTGGAGGAGCTGCG 3'), followed by reamplification with forward primer: 5' GAGGTACCATGAACCACAAGAGCA 3' and reverse primer: 5' CGCTCGAGTGGGGGTGAGCCCGGCCT 3' and ligated into TOPO pCR2.1 vector. All clones were sequence verified. <i>JMJD6</i> was cloned from TOPO vectors into a gateway entry vector pENTR3C (Invitrogen) and then recombined into the lentivirus vector pLenti6.2/V5-DEST (Invitrogen), pLenti4/V5-Dest (Invitrogen), and pcDNA3.1/V5-Dest (Invitrogen) by LR recombination, according to the manufacturer's protocol. For lentiviral clones, pLenti6.2/V5-DEST or pLenti4/V5-Dest was co-transfected with packaging vectors (Invitrogen) into 293 FT cells, and the supernatant was harvested approximately 48 hours for packaged lentivirus. For infection of MCF-7 cells, the cells were plated at 50% confluence and incubated with 20 l to 30 l of the concentrated virus and 8 g/ml of hexamethrine bromide (Polybrene) for 24 hours at 37C. The cells were replated and cultured with Zeocin (Invitrogen) to obtain several clones (MCF7-J1-OE). The pcDNA3.1 vector was used to generate <i>JMJD6</i> expression clones by transfection by using Lipofectamine 2000 (Invitrogen) into MDA-MB231, T47D, and CAMA cell lines. Stable clones were selected with gentamycin (Gibco).</p><h3 class="c-article__sub-heading" id="Sec8_3001">Knockdown of <i>JMJD6</i> gene</h3><p>SiRNA was reverse transfected (by using manufacturer's protocol) by using Lipofectamine 2000 (Invitrogen) into the cell lines. At 48 hours after transfection, the cells were reconstituted in fresh media for experimental assays. <i>JMJD6</i> siRNAs used were as follows: siRNA A (Ambion: 111915)- gcuauggugaacacccuaatt; siRNA B (Dharmacon: D-010363-01)- gaacugggauucacaucga; siRNA C (Dharmacon: D-010363-02)- ggauaacgauggcuacuca; and siRNA D (Dharmacon: D- 010363-05)- ggacccggcacaacuacua. A nontargeting scrambled siRNA served as a negative control (Ambion: 4635).</p><h3 class="c-article__sub-heading" id="Sec9_3001">Cell-based assays</h3><p>For proliferation assay, cells were plated in 96-well plates at a density of 5,000 cells per well. Cell proliferation was measured by using WST-1 (Roche) every 24 hours over a 4- to 5-consecutive-day period, according to manufacturer's protocol. For detecting apoptosis, cells were transfected in a 96-well plate with siRNAs and assessed for apoptotic markers after 48 hours. In brief, the cells were fixed with paraformaldehyde, and cells were permeabilized with Triton-X 100. Fixed cells were probed with active PARP (BD, 552596) antibody, and the primary antibodies were detected by a secondary antibody conjugated to fluors Alexa 488 (BD, A21121). ArrayScan VTI (Cellomics) was used to detect immunofluorescence, and the baseline threshold was set by using cells stained with secondary antibody alone in the absence of the primary antibody.</p><h3 class="c-article__sub-heading" id="Sec10_3001">Scatter assay</h3><p>Cells were plated in six-well plates at a density of 300 cells per well and grown in DMEM with 10% FBS. Fifteen fields of colonies per cell type were captured on day 7 of growth and blindly scored for three categories of scattering (compact, loose, and scatter) by two random individuals from six people. An average score was calculated for each colony, and the percentage of colonies for each category of scattering was plotted [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB: Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.&#xA;Cancer Res 2006, 66:1137011380." href="/articles/10.1186/bcr3200#ref-CR19_3001" id="ref-link-section-d167701133e1115">19</a>].</p><h3 class="c-article__sub-heading" id="Sec11_3001">Wound-healing assay</h3><p>Cells were plated in culture inserts (Ibidi) with approximately 500 <i>M</i> gap. After 2 days (confluent cells), the inserts were removed, and fresh medium with 5 g/ml of mitomycin C (Calbiochem, 47589) was added. The distances moved by the cells across the gap were measured at 24 hours and calculated as a ratio over the initial distance at 0 hours, and these data were further normalized to the ratio of distance in Vec control.</p><h3 class="c-article__sub-heading" id="Sec12_3001">Invasion and migration assay</h3><p>
<i>In vitro</i> migration and invasion of the cells were assessed by using Falcon FluoroBlok 24-Multiwell inserts with 8-m pores (BD Biosciences). For invasion assays, the inserts were coated with 20 g of Matrigel in 80 l of serum-free media. Cell suspension (200 l) in serum-free media was loaded into each transwell insert, and 750 l of medium with 10% FBS was provided in the lower chamber; 4  10<sup>4</sup> MDA-MB231/BT-549 cells were loaded in each transwell. The assay was done for 18 hours for migration and 24 hours for invasion. The cells that had migrated or invaded through the inserts were fixed with 3.7% formaldehyde and stained with propidium iodide, 2 g/ml (Calbiochem), for 30 minutes, washed with PBS, and counted for 10 fields by using the Target Activation Bioapplication on an ArrayScan VTI (Cellomics). Assay results for siRNA-treated MDA-MB231 cells were normalized to fold change observed in proliferation at Day 2 and then calculated as a ratio to the Sc siRNA control.</p><h3 class="c-article__sub-heading" id="Sec13_3001">Microarray data analysis</h3><p>MCF-7 J1 clones were harvested for RNA isolation at 80% confluence. For siRNA-mediated knockdown of <i>JMJD6</i> in MCF-7 and MDA-MB231, the cells were harvested for RNA isolation immediately, 48 hours after transfection. Cells were washed twice with PBS and harvested by trypsinization. RNA was extracted by Trizol (Invitrogen) according to manufacturer's protocol. Three biological replicates of MCF-7 J1 clones and two independent siRNA-transfection replicates were used for the microarray hybridization. Processing of samples for hybridization on Affymetrix U133 Plus 2.0 was done according to manufacturer's protocol. The microarray data were uploaded to Gene Expression Omnibus (accession number, GSE31782). Raw data were MAS5-normalized and log transformed by using Genespring GX11.5. To extract differential gene expression, GeneSpring GX 11.5 was used to perform two-way ANOVA for siRNA-specific changes in MCF-7 and MDA-MB231. The list of significantly differential genes (<i>P</i> &lt; 0.05) was further filtered for genes with at least 1.5-fold change in expression in at least one of the siRNA treatments for either MCF-7 or MDA-MB231. For MCF-7 J1-OE clones, one-way ANOVA was performed to extract differential gene expression in the overexpression clones as compared with the Vec. Only genes that differed in their expression by 1.5-fold in at least one of the clones were selected for further analysis. Genes that overlapped in both siRNA treatment and in J1 clones and those that were regulated in the opposite direction were selected for Ingenuity Pathway Analysis (IPA) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="&#xA;Ingenuity Systems&#xA;[&#xA;                    http://www.ingenuity.com&#xA;                    &#xA;                  ]" href="/articles/10.1186/bcr3200#ref-CR20_3001" id="ref-link-section-d167701133e1157">20</a>]. Hierarchical clustering by average linkage and visualization of the clusters was performed by using Cluster and Treeview, respectively [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns.&#xA;Proc Natl Acad Sci USA 1998, 95:1486314868." href="/articles/10.1186/bcr3200#ref-CR21_3001" id="ref-link-section-d167701133e1160">21</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Eisen M: TreeView. 1.60th edition. 2002." href="/articles/10.1186/bcr3200#ref-CR22_3001" id="ref-link-section-d167701133e1163">22</a>].</p><p>To extract differential gene expression specific to MDA-MB231, GeneSpring GX11.5 was used to perform one-way ANOVA in MDA-MB231 and MCF-7 independently. The list of significant genes that were differentially expressed (1.5-fold; <i>P</i> &lt; 0.05) was filtered. Probesets unique to MDA-MB231 that were absent in MCF-7 lists were extracted for IPA functional analysis.</p><h3 class="c-article__sub-heading" id="Sec14_3001">Real-time PCR</h3><p>Total RNA was reverse transcribed by using Maxima reverse transcriptase mix (Fermentas). Real-time PCR was performed by using SYBR-Green PCR Mix (Fermentas) and run on CFX384 Real Time PCR Detection System (Biorad). Ct values were generated by using CFX manager software (Biorad). The primers used are listed in the Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM2">2</a>, Table S2.</p><h3 class="c-article__sub-heading" id="Sec15_3001">Conditioned media</h3><p>To obtain conditioned media, plated cells were incubated with serum-free media for 24 hours before collection. The media were spun down to remove any cell debris and then concentrated 60 to 80 by using Amicon Ultra centrifugation filter (Millipore).</p><h3 class="c-article__sub-heading" id="Sec16_3001">Immunoblot analysis</h3><p>Whole-cell lysates were prepared by using RIPA buffer for all antibodies, except TGF-s, detected in conditioned media. Protein concentration was quantified by using Protein Assay reagent (Biorad) with BSA standards. Equal amounts of total protein lysates (20 to 40 g) were analyzed on an SDS-PAGE gel and transferred to PVDF membrane (GE Healthcare and Millipore). Antibodies against JMJD6 (Abcam, ab10526), -actin (Sigma, A5441), V5 tag (Invitrogen, R960-25), E-cadherin (Cell Signaling, 4065), vimentin (BD Pharmingen, 550513), TGF-2 (Abcam, ab36495), phosphorylated SMAD2 (Cell Signaling, 3108 and 3104), phosphorylated SMAD3 (Cell Signaling, 4520), SMAD2/3 (Cell Signaling, 3102), cyclin D1 (ab24249), cyclin E1 (Abcam, ab3927), and cyclin E2 (Abcam, ab40890) were used to probe for the protein on the membrane. The detection was done by using HRP-conjugated antibodies (Santa Cruz) and ECL or ECL Plus reagents (Amersham Biosciences). Reactive proteins were identified with autoradiography.</p><h3 class="c-article__sub-heading" id="Sec17_3001">TGF-2 neutralization and Smad phosphorylation assays</h3><p>Cells were plated in 96-well plates at a density of 5,000 cells per well and changed to fresh media with either 5 ng/ml of recombinant human (rh) TGF-2 (R&amp;D Systems, 302-B2) or BSA the next day. Cell-viability measurement was taken on the first day of TGF-2 or BSA treatment and 3 days later by using WST-1 assay. To inhibit TGF-2 action, cells were plated in 96-well plates at a density of 5,000 cells per well. After 24 hours, they were exposed to 10 <i>M</i> SB431542 (Sigma-Aldrich, S4317) or DMSO (as vehicle control) before transfection with JMJD6 siRNA. The cells were changed to fresh media 48 hours after transfection, containing 10 <i>M</i> SB431542 or DMSO. Cell viability was determined on the first day of SB431542 or DMSO treatment and 3 days later by WST-1 assay. For assessment of SMAD2 phosphorylation, cells were plated at approximately 50% confluence in six-well plates for 24 hours. The cells were pretreated for 2 hours with SB431542 (Sigma-Aldrich, S4317) or DMSO, before addition of 5 ng/ml of rhTGF-2 (R&amp;D Systems, 302-B2). Protein lysates were harvested 1 hour after rhTGF-2 treatment for immunoblot analysis.</p><h3 class="c-article__sub-heading" id="Sec18_3001">Clinical correlation between <i>TGF-2</i> and <i>JMJD6</i>
</h3><p>The super-cohort dataset was used to assess correlation, if any, between <i>JMJD6</i> and <i>TGF-2</i> expression. <i>TGF-2</i> probesets, 209908_s_at, 220407_s_at, 209909_s_at, and 220406_at, were averaged for the clinical microarray data analysis. Correlation of <i>JMJD6</i> expression and <i>TGF-2</i> expression was performed by using the Pearson correlation test on PASW Statistics 18 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="&#xA;PASW Statistics 18 18.0.0 edition. Chicago: SPSS Inc.; 2009." href="/articles/10.1186/bcr3200#ref-CR18_3001" id="ref-link-section-d167701133e1242">18</a>].</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec19_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec19_3001">Results</h2><div class="c-article-section__content" id="Sec19_3001-content"><h3 class="c-article__sub-heading" id="Sec20_3001">
<i>JMJD6</i> transcript levels correlate with poor prognosis in breast cancer</h3><p>To discover novel oncogenes associated with breast cancer progression, we used an informatics approach [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Soon WWML, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai K, Liu ET: Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.&#xA;EMBO Mol Med 2011, 3:451464." href="/articles/10.1186/bcr3200#ref-CR1_3001" id="ref-link-section-d167701133e1262">1</a>] and mined multiple independent microarray datasets of breast tumor profiles for genes having significant and reproducible associations with distant metastasis-free survival (DMFS). <i>JMJD6</i> emerged as a top candidate, because its expression was significantly and positively associated with decreased time to distant metastasis in eight of the 14 breast cancer cohorts examined (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig1">1</a> and Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM1">1</a>, Table S1). Furthermore, in an integrated Super Cohort (SC) (<i>n</i> = 1,954) comprising the majority of the individual cohorts listed in Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/bcr3200#Tab1">1</a> (see Methods and Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM1">1</a>, Table S1), high <i>JMJD6</i> expression was significantly associated with decreased time to distant metastasis with a hazard ratio of 1.92 (95% CI, 1.62 to 2.29; <i>P</i> &lt; 0.001). Together, these observations indicate a robust and reproducible association between <i>JMJD6</i> expression and aggressive clinical behavior of breast cancer that may reflect an underlying functional contribution of <i>JMJD6</i> in breast cancer progression.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Figure 1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig1_HTML.jpg?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig1_HTML.jpg" alt="figure 1" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>
<b>High</b>
<b><i>JMJD6</i></b>
<b>mRNA expression is associated with poor survival outcome</b>. Cox regression analysis of <i>JMJD6</i> expression and distant metastasis-free survival of patients was initially performed in 14 microarray expression datasets independently and then subsequently on a "Super Cohort" (SC) comprising 15 Affymetrix array-based cohorts, including a subset of the 14 cohorts used initially. Hazard ratios and their 95% confidence intervals are shown in the forest plot. Datasets are listed on the Y-axis; all platforms are from Affymetrix array series, with the exception of NKI from Agilent. The 95% confidence intervals are indicated by the error bars, and the cohort size is shown in parentheses. *<i>P</i>  0.05; **<i>P</i>  0.01; ***<i>P</i>  0.005.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Table 1 Hazard ratios of <i>JMJD6</i> expression groups in various subtypes of breast cancer</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/10.1186/bcr3200/tables/1" aria-label="Full size table 1"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec21_3001">
<i>JMJD6</i> expression in breast cancer subtypes</h3><p>Breast cancers were classified based on hormone-receptor status, estrogen receptor (ER<sup>+/-</sup>), or gene expression into intrinsic subtypes as described by Perou <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM: Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.&#xA;Genome Biol 2007, 8:R76." href="/articles/10.1186/bcr3200#ref-CR23_3001" id="ref-link-section-d167701133e1700">23</a>]. Because these subclasses show differential survival, we analyzed the expression level of <i>JMJD6</i> in each subtype annotated in the Super Cohort. As shown in Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2A</a>, overall ER<sup>-</sup> tumors had slightly but significantly elevated expression of <i>JMJD6</i> (<i>P</i> &lt; 0.001). The average <i>JMJD6</i> expression differed across the intrinsic subtypes. <i>JMJD6</i> expression was highest in Claudin-low tumors and basal subtypes, followed by HER2, whereas in the ER<sup>+</sup> group, the luminal B (LumB) expressed more <i>JMJD6</i> than did luminal A (LumA) (<i>P</i> &lt; 0.05) (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2B</a>). We examined the survival outcome of <i>JMJD6</i> high- and low-expresser groups, determined by median separation across the Super Cohort, within each subtype. Because ER<sup>-</sup> tumors had very high levels of <i>JMJD6</i> expression, further separation based on <i>JMJD6</i> levels and survival analysis bore no significance (Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/bcr3200#Tab1">1</a>). In ER<sup>+</sup> tumors, high <i>JMJD6</i> expressers had poorer outcome than low expressers (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2C</a>; <i>P</i> &lt; 0.001), and this persisted on subdivision of ER<sup>+</sup> into luminal subclasses (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2D</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2E</a>). Further, in the tamoxifen-treated samples, high <i>JMJD6</i> expressers had worse outcome. However, whether <i>JMJD6</i> predicts endocrine failure must be studied further. These data are summarized in Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/10.1186/bcr3200#Tab1">1</a>. Other than total cohort median-based separation of patients, we also examined the relation of <i>JMJD6</i> levels and prognosis by quartile assignment of <i>JMJD6</i> expression in each subtype independently. With this method, we observed that extremely high expression of <i>JMJD6</i> (upper quartile) significantly led to worse survival outcomes in luminal A and luminal B subtypes (<i>P</i> &lt; 0.05) (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM3">3</a>, Figure S1). Therefore, we conclude that <i>JMJD6</i> is a marker for tumor aggressiveness and maybe is prognostic of poor outcome in ER<sup>+</sup> breast cancer.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Figure 2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig2_HTML.jpg?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig2_HTML.jpg" alt="figure 2" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>
<b><i>JMJD6</i></b>
<b>expression and prognosis in intrinsic subtypes of breast cancer</b>. Box plots of <i>JMJD6</i> expression demonstrate <b>(A)</b> higher <i>JMJD6</i> probeset intensity (log2) in ER<sup>-</sup> tumors compared with ER<sup>+</sup> tumors, with <i>P</i> &lt; 0.001 by Mann-Whitney Rank Sum test; and <b>(B)</b> highest <i>JMJD6</i> probeset intensity (log2) in claudin-low and basal subtypes, followed by <i>HER2</i>-enriched and LumB subtypes, and lowest in LumA subtypes. The Dunn method was used to perform pairwise multiple comparison among the subtypes. *<i>P</i> &lt; 0.05 between a pair of subtypes. Dots of boxplots (A, B) represent outliers in the 90<sup>th</sup> and 10<sup>th</sup> percentiles. Kaplan-Meier survival curves based on below-median (low) and above-median (high) <i>JMJD6</i> expression are shown for <b>(C)</b> ER<sup>+</sup> patients, <b>(D)</b> patients of LumA subtype, <b>(E)</b> patients of LumB subtype, and <b>(F)</b> ER<sup>+</sup>, tamoxifen-treated patients. The numbers in the parentheses equal patient numbers in each group, and the log rank <i>P</i> value is indicated at the bottom left of each figure.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec22_3001">JMJD6 protein associates with high-grade and ER<sup>-</sup> tumors</h3><p>To study the distribution of JMJD6 protein levels, we immunohistochemically (IHC) stained an 81-breast tumor tissue array by using a JMJD6-specific antibody (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig3">3A</a>). MCF-7-J1 OE and JMJD6 siRNA-treated cells were used to confirm the specificity of the antibody (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM4">4</a>, Figure S2). As shown, JMJD6 was present predominantly in the nuclei of breast tumor cells, with increased staining evident in higher grades of breast tumors. Univariate analysis clearly identified an association between high JMJD6 staining, high grade, and ER negativity (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig3">3B</a>). Similar to the RNA-expression data, JMJD6 protein was highly expressed in more-aggressive and advanced tumors. However, because of the low sample size, our analysis could not explore whether JMJD6 correlates with outcome in luminal tumors. Nonetheless, JMJD6 appears to be a relevant marker in breast cancer pathogenesis.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Figure 3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig3_HTML.jpg?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig3_HTML.jpg" alt="figure 3" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>
<b>Nuclear JMJD6 protein expression is associated with high-grade breast tumors</b>. Representative breast cancer cores from tissue microarray that were stained with JMJD6 antibody are shown. Low-grade (left panel), intermediate-grade (middle panel), and high-grade breast tumors (right panel) are shown (magnification, 60). The table in the figure shows univariate analysis of JMJD6 and clinical parameters.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec23_3001">JMJD6 increases proliferation in MCF-7 cells</h3><p>Because the <i>JMJD6</i> expression profile was similar to the proliferative gene cluster, as characterized by Perou <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Prat A, Parker J, Karginova O, Fan C, Livasy C, Herschkowitz J, He X, Perou C: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.&#xA;Breast Cancer Res 2010, 12:R68." href="/articles/10.1186/bcr3200#ref-CR14_3001" id="ref-link-section-d167701133e1940">14</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Srlie T: Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.&#xA;Eur J Cancer 2004, 40:26672675." href="/articles/10.1186/bcr3200#ref-CR24_3001" id="ref-link-section-d167701133e1943">24</a>], we posited that perturbation of its levels may affect cell proliferation (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2A</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig2">2B</a>). We studied JMJD6 expression in a panel of five breast cancer cell lines (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM5">5</a>, Figure S3A). With the exception of MCF-7 cells, JMJD6 was highly expressed in breast cancer cell lines. We used a lentiviral-based cloning system to infect MCF-7 cells with V5-tagged JMJD6 and achieved stable expression of JMJD6 (MCF-7 J1-OE). As a pool, these cells showed increased proliferation (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM6">6</a>, Figure S4), and this was confirmed in individual clones, J1-C2, J1-C3, and J1-C7 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig4">4A</a>). Over a period of 5 days, MCF-7-J1-OE clones (J1-C2, J1-C3, and J1-C7) showed higher proliferation as early as day 2 and continued to grow faster as compared with empty vector control cells (Vec) (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig4">4A</a>). Next we silenced <i>JMJD6</i> expression in all five cell lines by using a panel of siRNAs and assayed their proliferation. We achieved 80% to 100% silencing of JMJD6 protein, depending on the basal, endogenous expression level of JMJD6 (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM5">5</a>, Figure S3A). Four different siRNAs resulted in profound loss of proliferation in MCF-7 and MDA MB231 cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig4">4B</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig4">4C</a>). This decrease was not due to increased apoptosis, because higher levels of cleaved PARP were not evident in the JMJD6 knockdown cells (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM5">5</a>, Figure S3B). Similar to MCF7 and MDA-MB231, siRNA treatment decreased proliferation in the remaining cell lines: BT-549, CAMA-1, and T47D (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM5">5</a>, Figure S3C). Together, these results suggest that high levels of JMJD6 lead to increased cell proliferation. To determine whether further induction of JMJD6 in cells with intrinsically higher JMJD6 levels shows an additive increase in cell proliferation, we generated MB231-J1-OE, T47D-J1-OE, and CAMA-J1-OE cells (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM7">7</a>, Figure S5). However, an increased dosage of JMJD6 did not further augment cell growth</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Figure 4"><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 4</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig4_HTML.jpg?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig4_HTML.jpg" alt="figure 4" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p>
<b>Expression of JMJD6 enhances proliferation</b>. <b>(A)</b> WST-1 assays using MCF-7-J1-OE clones (J1-C2, J1-C3, and J1-C7) showed increased proliferation over vector control cells (Vec). SiRNA-mediated knockdown of JMJD6 and resultant decrease in proliferation is shown in <b>(B)</b> MCF-7 and MDA-MB231. Four individual siRNAs (A, B, C, and D) were used: Sc, scrambled siRNA; and NT, non-transfected cells served as control. Inset in each panel shows protein levels of JMJD6 after siRNA transfection. -actin immunoblots show equal protein loading in all lanes.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec24_3001">JMJD6 enhances scattering and motility</h3><p>Our <i>in silico</i> analysis and IHC data showed that <i>JMJD6</i> is associated with aggressive advanced disease. We next studied whether this protein could influence cell motility and invasion by using cell-scatter, wound-healing, and Boyden chamber assays. The motility and invasion assays were performed within 24 hours to minimize secondary effects of cell proliferation. For the scattering phenotype, we used a counting system previously described by Shtutman <i>et al.</i> [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB: Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.&#xA;Cancer Res 2006, 66:1137011380." href="/articles/10.1186/bcr3200#ref-CR19_3001" id="ref-link-section-d167701133e2034">19</a>] to evaluate the degree of scattering (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig5">5A</a>). All three MCF-7-J1-OE clones showed an increase in scattering as compared with Vec cells. An increase in scattering often implies a gain in motility or epithelial-mesenchymal transformation (EMT). Therefore, we assayed loss of E-cadherin and gain in vimentin as markers for EMT. Immunoblots showed that MCF-7J1-OE clones maintained E-cad expression (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM8">8</a>, Figure S6), suggesting that the scattering is probably encouraged by motility. Indeed, in a wound-healing assay, MCF-7-J1-OE clones closed the wound much faster than did Vec cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig5">5B</a>). Because increased cell number due to increased proliferation can mislead interpretation of wound-healing data; we performed these assays in the presence of mitomycin C, an inhibitor of cell division. Despite a gain in motility, we were unable to demonstrate an increase in invasive behavior in MCF-7-J1-OE cells (data not shown). However, in MDA-MB231, a highly motile and invasive cell line, knockdown of JMJD6 significantly attenuated both properties (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig5">5C</a>). To negate the contribution of decreased proliferation in this assay, we normalized these results to the proliferation changes observed on day 2 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig5">5C</a>). However, the cells maintained loss in motility and invasion, showing that this property was independent of proliferation defects. Together, these data imply that JMJD6 is not a "driver" of cell invasion but may augment cell movement.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Figure 5"><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 5</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig5_HTML.jpg?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig5_HTML.jpg" alt="figure 5" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p>
<b>JMJD6 promotes motility in breast cancer cell lines</b>. <b>(A)</b> Scatter phenotype was scored based on three levels of scattering (compact, loose, scatter) (upper panel). Bar graphs represent quantification of scattering of colonies by using the Student <i>t</i> test (lower panel). MCF-7 J1 OE clones had a higher percentage of scattered or loosely scattered clones than did the control Vec cells. <b>(B)</b> Wound-healing assay showed that MCF-7 J1 clones displayed higher motility in comparison to Vec (upper panel); quantification of wound closure as a ratio to the Vec is shown in the lower panel. *<i>P</i>  0.05 by Student <i>t</i> test in comparison to Vec control. <b>(C)</b> Boyden-chamber assay results of MDA-MB231 cells with JMJD6 siRNA-mediated knockdown were normalized to fold change in proliferation at Day 2 of WST-1 measurement. Two of three siRNA knockdowns of JMJD6 showed significantly decreased motility, and all siRNA knockdowns of JMJD6 showed decreased invasiveness. *<i>P</i>  0.05; **<i>P</i>  0.001 by Student's t- test when compared with Sc siRNA.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec25_3001">
<i>JMJD6</i> expression inversely correlates with <i>TGF-2</i>
</h3><p>To determine the pathways involved in JMJD6-induced proliferation, we performed microarray analysis by using the MCF-7-J1-OE clones and <i>JMJD6</i> siRNA-treated MCF-7 and MDA-MB231 cells. We selected 2,216 overlapping probe sets that were commonly and appropriately regulated in all three settings: MCF-7-J1-OE, MCF-7 siRNA, and MDA-MB231 siRNA (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM9">9</a>, Table S3). Clusters of genes regulated in the opposite directions in JMJD6 overexpression and JMJD6 knockdown were denoted JMJD6-induced and JMJD6-repressed gene sets, respectively (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig6">6</a>). We analyzed these two gene sets with Ingenuity Pathway Analysis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="&#xA;Ingenuity Systems&#xA;[&#xA;                    http://www.ingenuity.com&#xA;                    &#xA;                  ]" href="/articles/10.1186/bcr3200#ref-CR20_3001" id="ref-link-section-d167701133e2124">20</a>]. In accordance with our cell-based assays, in the JMJD6-induced gene set, the top enriched functions were cell-cycle and DNA replication, followed by cellular assembly and cellular movement (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig6">6</a>; see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM10">10</a>, Table S4). In the JMJD6-repressed subset, a large number of genes were related to cancer function (120) (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig6">6</a>). Among the associated gene functions, we observed a significant downregulation of <i>TGF-</i> isoforms, the classic cell-cycle inhibitors [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Moses HL: TGF-beta regulation of epithelial cell proliferation.&#xA;Mol Reprod Dev 1992, 32:179184." href="/articles/10.1186/bcr3200#ref-CR25_3001" id="ref-link-section-d167701133e2140">25</a><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Ravitz MJWC: Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.&#xA;Adv Cancer Res 1997, 71:165207." href="/articles/10.1186/bcr3200#ref-CR27_3001" id="ref-link-section-d167701133e2143">27</a>] (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM10">10</a>, Table S4), which was further confirmed by using quantitative RT-PCR. Loss of JMJD6 increased <i>TGF-1</i> and <i>TGF-2</i> expression, whereas <i>TGF-3</i> was unaffected in both MCF-7 and MDA-MB231 (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig7">7A</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig7">7B</a>). Protein analysis suggested that both JMJD6 siRNAs induced a high level of TGF-2 secretion in the two cell lines (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig7">7C</a>). In contrast, in MCF-7-J1-OE cells, a significant decrease in <i>TGF-2</i> mRNA and protein expression was observed (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig7">7D</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig7">7E</a>). At the protein level, we failed to detect changes in TGF-1 and TGF-3, although both isoforms were expressed (data not shown). Therefore, of the three isoforms, TGF-2 probably was more engaged in JMJD6-mediated cellular proliferation.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6" data-title="Figure 6"><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 6</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/6" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig6_HTML.jpg?as=webp"><img aria-describedby="Fig6" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig6_HTML.jpg" alt="figure 6" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p>
<b>IPA analysis of JMJD6-regulated genes showed enrichment in cell-cycle function</b>. <b>(A)</b> The heatmap (top panel) shows that hierarchic clustering of the genes changed after siRNA knockdown and overexpression of <i>JMJD6</i>. The sample labels are on the top of the heat map. Two clusters representing JMJD6-induced and JMJD6-repressed genes were selected (middle heat-map panel) and subjected to IPA analysis. <b>(B)</b> Table shows a list of the top 10 functions that are enriched in cells with altered levels of JMJD6.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/6" data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-7" data-title="Figure 7"><figure><figcaption><b id="Fig7" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 7</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/7" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig7_HTML.jpg?as=webp"><img aria-describedby="Fig7" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig7_HTML.jpg" alt="figure 7" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-7-desc"><p>
<b>JMJD6 represses TGF-2 expression</b>. RT-qPCR assays of <i>TGF-s</i> after <i>JMJD6</i> siRNA-mediated knockdown are shown in <b>(A)</b> MCF-7 and <b>(B)</b> MDA-MB231. Consistently, T<i>GF-2</i> and <i>TGF-1</i> mRNA levels were upregulated on JMJD6 knockdown. <b>(C)</b> Immunoblots showed that the amount of secreted TGF-2 protein in conditioned media was higher after <i>JMJD6</i> siRNA-mediated knockdown in MCF-7 and MDA-MB231. <b>(D)</b> RT-qPCR assay showed that MCF7 J1 OE clones had a lower level of <i>TGF-1</i> and <i>TGF-2</i> transcripts than did the Vec cells. <b>(E)</b> Western blot showed a dramatic decrease in secreted TGF-2 protein, in the MCF-7 J1 clones, as compared with the Vec cells. NS, a Ponceau-stained blot of the conditioned media to demonstrate protein loading. Student's t<i>-</i> test was performed by using scrambled siRNA versus JMJD6 siRNA and Vec cells versus MCF-7J1 clones. *<i>P</i>  0.05; **<i>P</i>  0.005.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/7" data-track-dest="link:Figure7 Full size image" aria-label="Full size image figure 7" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec26_3001">JMJD6 possibly engages multiple pathways to increase cell proliferation</h3><p>JMJD6 suppressed <i>TGF-2</i> expression and cell proliferation in both MCF-7 and MDA-MB 231 cells. However, TGF-2 mediates cell-cycle arrest only in MCF-7 cells, but not in MDA-MB 231, T47D, and CAMA-1 cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT: Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.&#xA;J Clin Invest 1993, 92:25692576." href="/articles/10.1186/bcr3200#ref-CR28_3001" id="ref-link-section-d167701133e2289">28</a><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Fanayan S, Firth SM, Butt AJ, Baxter RC: Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-(TGF-) and the type II TGF- receptor.&#xA;J Biol Chem 2000, 275:3914639151." href="/articles/10.1186/bcr3200#ref-CR30_3001" id="ref-link-section-d167701133e2292">30</a>]. Therefore, TGF-2 may not be the mediator of cell-cycle arrest in the latter three cell lines, even though MDA-MB231s are responsive to TGF- in terms of SMAD phosphorylation and TGF--mediated transcriptional changes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Chen CR, Kang Y, Massagu J: Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor  growth arrest program.&#xA;Proc Natl Acad Sci USA 2001, 98:992999." href="/articles/10.1186/bcr3200#ref-CR31_3001" id="ref-link-section-d167701133e2295">31</a>]. To test the functionality of TGF- 2, we did the following: (a) assessed Smad2/3 phosphorylation levels in both cells, (b) neutralized TGF-2 by using a TGF- type I receptor inhibitor SB431542 and assayed Smad phosphorylation and cell proliferation in the absence of JMJD6, and (c) treated MCF-7-J1OE cells with recombinant TGF- 2.</p><p>By treatment of recombinant TGF-2 on MCF-7 and MDA-MB231, we confirmed that both cell lines responded with increased SMAD2 phosphorylation, which suggests intact TGF- receptor signaling (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig8">8</a>; see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM11">11</a>, Figure S7A). Similarly, an increase in SMAD2 and SMAD3 phosphorylation with <i>JMJD6</i> siRNA treatment was seen in both MCF-7 and MDA-MB231, as opposed to a decrease observed in the MCF-7 J1 OE clones (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig8">8</a>). Interestingly, basal SMAD levels themselves were affected, which parallels the transcript-level change detected in our expression array (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig6">6</a>). When we inhibited SMAD phosphorylation by using an Alk-5 receptor inhibitor (SB431542), we observed a significantly higher rescue of proliferation in MCF-7 <i>JMJD6</i> knockdown cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig9">9A</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig9">9B</a>). Because MDA-MB 231 cells are refractory to TGF-2-mediated cell-cycle inhibition, SB431542 should have no effect on MDA-MB231 growth suppression. Accordingly, the suppressed proliferation could not be rescued by the Alk-5 receptor inhibitor treatment in this cell type (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM11">11</a>, Figure S7).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-8" data-title="Figure 8"><figure><figcaption><b id="Fig8" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 8</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/8" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig8_HTML.jpg?as=webp"><img aria-describedby="Fig8" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig8_HTML.jpg" alt="figure 8" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-8-desc"><p>
<b>JMJD6 expression affects SMAD phosphorylation</b>. Immunoblots show that the levels of total SMAD2/3, phosphorylated SMAD2, and phosphorylated SMAD3 are decreased in MCF-7 J1-OE clones and increased in JMJD6 siRNA-mediated knockdown in MCF-7 and MDA-MB231. The numbers next to the SMAD2P/3P denote the expected sites of phosphorylation detected by the antibodies. NS, nonspecific bands from the blots, which indicate equal loading of the protein lysates.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/8" data-track-dest="link:Figure8 Full size image" aria-label="Full size image figure 8" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-9" data-title="Figure 9"><figure><figcaption><b id="Fig9" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 9</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/9" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig9_HTML.jpg?as=webp"><img aria-describedby="Fig9" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig9_HTML.jpg" alt="figure 9" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-9-desc"><p>
<b>TGF-2 inhibits proliferation in MCF-7</b>. <b>(A)</b> Immunoblots showed that treatment of MCF-7 by recombinant human (rh) TGF-2 (5 ng/ml) resulted in enhanced Smad2 phosphorylation, which could be effectively nullified by SB431542. <b>(B)</b> Treatment of JMJD6 siRNA-transfected MCF-7 cells with SB431542 (10 <i>M</i>) resulted in rescue of the proliferation defect. Ratio of OD at Day 3 to Day 1 in JMJD6 knockdown cells was normalized to the scrambled siRNA control. *<i>P</i>  0.05; **<i>P</i>  0.005 between DMSO and SB431542 treatments. <b>(C)</b> Treatment of MCF-7 J1-OE and Vec cells with rhTGF-2 resulted in decreased proliferation, as measured by WST-1 assay. **<i>P</i>  0.001 between BSA and rhTGF-2 treatments.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/9" data-track-dest="link:Figure9 Full size image" aria-label="Full size image figure 9" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<p>Last, treatment of MCF-7 J1-OE cells with recombinant TGF-2 repressed proliferation in both Vec and J1-OE cells, suggesting that MCF-7 retained sensitivity to TGF-2-mediated growth regulation despite increased JMJD6 levels (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig9">9C</a>). Therefore, JMJD6 did not confer unresponsiveness to this growth factor, but probably mediated its effect via repression of gene expression. Together these data suggest that in MCF-7 cells, JMJD6 mediates cell-cycle regulation, in part by suppressing <i>TGF-2</i>.</p><p>Secretion of TGF-2 cannot explain the growth arrest in <i>JMJD6</i> siRNA-treated MDA MB 231 cells. Scanning of microarray data revealed that JMJD6 changed the levels of G<sub>1</sub> cyclins: <i>cyclins E1, E2</i>, and <i>D</i> at the RNA level. In MDA MB 231 cells, we confirmed a loss in cyclin E2 protein expression but not E1 or cyclin D in JMJD6 siRNA-containing cells (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig10">10</a>). Interestingly, cyclin E1/E2 was decreased in MCF-7 <i>JMJD6</i> siRNA-treated cells and induced in MCF-7-J1 OE cells and (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig10">10</a>). Together these data indicate that in both cells, JMJD6 mediated suppression of <i>TGF-2</i>. In MCF-7 cells, the proliferation is controlled by both TGF-2 and cyclin E regulation, but in MDA 231 cells, the cyclin E regulation may contribute to this phenotype, rather than TGF-2 signaling. Other pathways that operate in MDA-MB 231 cells must be explored further.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-10" data-title="Figure 10"><figure><figcaption><b id="Fig10" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 10</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/10" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig10_HTML.jpg?as=webp"><img aria-describedby="Fig10" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig10_HTML.jpg" alt="figure 10" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-10-desc"><p>
<b>Decrease of cyclin E2 protein level in JMJD6 knockdown</b>. Western blot detection of G<sub>1</sub> cell-cycle cyclins is shown. A decrease in cyclin E2 (CCNE2) level with decrease in JMJD6 levels was evident in MCF-7 and MDA-MB231. Cyclin E1 (CCNE1) and cyclin D1 (CCND1) displayed an inconsistent change on JMJD6 siRNA transfection in both MCF-7 and MDA-MB231 cells.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/10" data-track-dest="link:Figure10 Full size image" aria-label="Full size image figure 10" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
<h3 class="c-article__sub-heading" id="Sec27_3001">Clinical data for <i>JMJD6</i> and <i>TGF-2</i>
</h3><p>Finally, by using expression data from the clinical cohorts, we observed a marginal but significant inverse correlation <i>of JMJD6</i> with <i>TGF-2</i> (Pearson correlation value, -0.118; <i>P</i> value = 9.13  10<sup>-8</sup>) (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig11">11</a>). This suggests that this <i>TGF-2</i> mechanism observed <i>in vitro</i> could be extrapolated to patient data and that the MCF-7-OE cells could serve as a model system to explore the pathways involved in further detail.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-11" data-title="Figure 11"><figure><figcaption><b id="Fig11" class="c-article-section__figure-caption" data-test="figure-caption-text">Figure 11</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/11" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig11_HTML.jpg?as=webp"><img aria-describedby="Fig11" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_Fig11_HTML.jpg" alt="figure 11" loading="lazy"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-11-desc"><p>
<b>Clinical association of</b>
<b><i>JMJD6</i></b>
<b>with</b>
<b><i>TGF-2</i></b>. Pearson correlation of clinical expression of <i>JMJD6</i> with <i>TGF-2</i> suggests a negative correlation with <i>TGF-2</i> (<i>P</i> = 9.13  10<sup>-8</sup>). Scatterplot shows the normalized <i>JMJD6</i> expression of each patient sample with the corresponding normalized <i>TGF-2</i> expression in the clinical dataset of 2,034 breast cancer patients.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/10.1186/bcr3200/figures/11" data-track-dest="link:Figure11 Full size image" aria-label="Full size image figure 11" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-chevron-right"></use></svg></a></div></figure></div>
</div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec28_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec28_3001">Discussion</h2><div class="c-article-section__content" id="Sec28_3001-content"><p>Through microarray informatics, we identified <i>JMJD6</i> as a candidate oncogene associated with poor patient prognosis. Consistent with its potential as a marker of breast cancer aggressiveness, <i>JMJD6</i> was expressed at highest levels in ER<sup>-</sup>, basal, claudin-low, <i>HER2</i>-enriched, and Luminal B tumor subtypes, which are known to be clinically associated with poor patient outcomes. Most important, in the less-aggressive ER<sup>+</sup> subtypes (for example, Luminal A), high levels of <i>JMJD6</i> could predict poor outcome and possibly resistance to tamoxifen monotherapy. Protein analysis by using tissue microarray confirmed that high <i>JMJD6</i> expression is consistently associated with ER<sup>-</sup> disease, higher grade, and advanced stage. These data demonstrate for the first time that JMJD6 is a relevant prognostic biomarker in breast cancer.</p><p>By phenotypic and functional analysis, we found that <i>JMJD6</i> induced an increase in cell scattering and increased the rate of wound closure in MCF-7 cells, but did not confer an invasive phenotype. In invasive cells like MDA-MB231 and BT-549 with high expression of <i>JMJD6</i>, siRNA-mediated suppression led to loss of both motility and invasiveness properties. Because forced <i>JMJD6</i> expression did not confer invasiveness, this apparent loss of invasiveness most likely follows a loss in motility. Nonetheless, JMJD6 may have a critical role in epithelial cell movement, and we showed that this property is not restricted to endothelial cells [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Boeckel J-N, Guarani V, Koyanagi M, Roexe T, Lengeling A, Schermuly RT, Gellert P, Braun T, Zeiher A, Dimmeler S: Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1.&#xA;Proc Natl Acad Sci USA 2011, 108:32763281." href="/articles/10.1186/bcr3200#ref-CR7_3001" id="ref-link-section-d167701133e2586">7</a>]. However, this appears to be a minor function of JMJD6, because its exogenous expression did not induce epithelial-to-mesenchymal transition (EMT) (that is, we did not observe a loss or gain in E-cadherin or vimentin expression, respectively, in MCF-7 J1-OE cells).</p><p>The most prominent effect of JMJD6 perturbation was on cell proliferation. SiRNA-mediated attenuation of JMJD6 in multiple breast cancer cells led to a decrease in cell proliferation without activation of cellular apoptosis, whereas forced expression in MCF-7 resulted in a massive increase in cell proliferation. This finding is consistent with the observation that JMJD6-knockout mice are small and show growth retardation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Bose J, Gruber A, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A: The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal.&#xA;J Biol 2004, 3:15." href="/articles/10.1186/bcr3200#ref-CR3_3001" id="ref-link-section-d167701133e2592">3</a>]. The role of JMJD6 in proliferation is further substantiated by our microarray analysis, which revealed that modulation of JMJD6 expression significantly affected the expression levels of a number of cell cycle-associated genes (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM10">10</a>, Table S4). Although <i>JMJD6</i> is thought to mediate splicing by physical interaction with U2AF65, we obtained very little evidence for alternate transcripts in both cell lines. Conversely, we documented a large number of transcriptional changes in J1-OE clones and JMJD6 knockdowns.</p><p>The TGF- pathway, particularly TGF-2, was downregulated when JMJD6 was overexpressed and induced when JMJD6 was depleted. We validated the inverse relation between <i>JMJD6</i> and <i>TGF-2</i> at both RNA and protein levels in these cellular systems. We extended this observation to clinical samples and observed an inverse correlation between <i>JMJD6</i> and <i>TGF-2</i> in our breast cancer cohorts. Such antagonistic roles of JMJD6 and TGF-2 have a precedent in eye development. One of the distinctive developmental defects of JMJD6-knockout mice is the thinning of the retinal layer [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Bose J, Gruber A, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A: The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal.&#xA;J Biol 2004, 3:15." href="/articles/10.1186/bcr3200#ref-CR3_3001" id="ref-link-section-d167701133e2616">3</a>]. Coincidentally, the knockout of TGF-2 results in the hyperplasia of the neuroblastic layer of the retina [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T: TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.&#xA;Development 1997, 124:26592670." href="/articles/10.1186/bcr3200#ref-CR32_3001" id="ref-link-section-d167701133e2620">32</a>]. These data suggest that JMJD6 and TGF-2 may be functionally linked in cell-cycle regulation and in development.</p><p>Canonically, TGF-s are known to exert antiproliferative effects by upregulating cyclin-dependent kinase inhibitors, p15 and p21, and/or downregulation of CDK2 and cyclin E activity [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Robson CN, Gnanapragasam V, Byrne RL, Collins AT, Neal DE: Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.&#xA;J Endocrinol 1999, 160:257266." href="/articles/10.1186/bcr3200#ref-CR26_3001" id="ref-link-section-d167701133e2627">26</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Ravitz MJWC: Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.&#xA;Adv Cancer Res 1997, 71:165207." href="/articles/10.1186/bcr3200#ref-CR27_3001" id="ref-link-section-d167701133e2630">27</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Geng Y, Weinberg RA: Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.&#xA;Proc Natl Acad Sci USA 1993, 90:1031510319." href="/articles/10.1186/bcr3200#ref-CR33_3001" id="ref-link-section-d167701133e2633">33</a><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.&#xA;Proc Natl Acad Sci USA 1995, 92:55455549." href="/articles/10.1186/bcr3200#ref-CR35_3001" id="ref-link-section-d167701133e2636">35</a>]. In both MCF-7 and MDA-MB 231 transfected with <i>JMJD6</i> siRNA, we observed suppression of cyclin E expression, and an increase in cyclin E was evident when <i>JMJD6</i> was overexpressed in MCF-7 cells. Therefore, in both cell lines, JMJD6 may exert a proliferative effect through a direct increase in cyclin E protein levels, or this increase may be a consequence of JMJD6-mediated suppression of TGF-2. In both MCF-7 and MDA-MB231, the downstream effectors, Smads, were phosphorylated on JMJD6 siRNA-mediated secretion of TGF-2. Specifically, in MCF-7, inhibition of TGF- activity by using a TGF- type I receptor (Alk5) inhibitor resulted in the loss of Smad phosphorylation, rescue of arrested cells, and continuation of proliferation (Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/10.1186/bcr3200#Fig9">9</a>). The Alk5 inhibitor did not reverse cell-cycle arrest in MDA-MB 231 cells because they are refractory to the antiproliferative effect of TGF-, suggesting that the JMJD6-cyclin E axis may function independent of TGF-2 in these cells. Intriguingly, cyclin E is associated with poor prognosis, chromosomal instability, and trastuzumab resistance, suggesting that the long-term dysregulation of cell-cycle mediators by JMJD6 may affect more than just proliferation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS: Cyclin E and survival in patients with breast cancer.&#xA;N Engl J Med 2002, 347:15661575." href="/articles/10.1186/bcr3200#ref-CR36_3001" id="ref-link-section-d167701133e2649">36</a><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Scaltriti M, Eichhorn PJ, Corts J, Prudkin L, Aura C, Jimnez J, Chandarlapaty S, Serra V, Prat A, Ibrahim YH, Guzmn M, Gili M, Rodrguez O, Rodrguez S, Prez J, Green SR, Mai S, Rosen N, Hudis C, Baselga J: Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.&#xA;Proc Natl Acad Sci USA 2011, 108:37613766." href="/articles/10.1186/bcr3200#ref-CR38_3001" id="ref-link-section-d167701133e2652">38</a>].</p><p>Our initial microarray analysis selected genes that were commonly regulated by JMJD6 in both MCF-7 and MDA-MB 231 cells. To elucidate further the mechanisms behind <i>JMJD6</i> siRNA-mediated growth suppression in MDA-MB 231 cells, we reanalyzed gene-expression changes unique to MDA-MB 231 cells alone. We found 1,864 probesets, with significant enrichment of genes involved in cellular death, growth and proliferation, and cell movement (<i>P</i> &lt; 0.01; see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM12">12</a>, Figure S8). Close inspection showed at least 28 individual genes in this proliferation gene cassette (see Additional file <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM13">13</a>, Table S5); however, no connectivity or compelling pathway emerged that could be investigated further.</p></div></div></section><section data-title="Conclusion"><div class="c-article-section" id="Sec29_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec29_3001">Conclusion</h2><div class="c-article-section__content" id="Sec29_3001-content"><p>In summary, our data indicate that <i>JMJD6</i> has conserved functions and often affects similar pathways in a congruent manner across multiple cell types and at a gene-expression and phenotypic level. JMJD6 has ability to promote cancer cell proliferation and motility, which in turn may augment cancer virulence <i>in vivo</i>. In the clinic, JMJD6 associates with advanced grade, an aggressive phenotype, and serves as a marker of poor prognosis in breast cancer. We propose that JMJD6 staining (with IHC) may serve a dual purpose in the clinic: to predict poor outcome in patients, particularly in the ER<sup>+</sup> subtype, and to identify a patient subgroup wherein specific inhibitors of JMJD6 may facilitate the pathologic downstaging of tumors in the neoadjuvant setting.</p></div></div></section>
                    <section data-title="Abbreviations"><div class="c-article-section" id="abbreviations-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="abbreviations">Abbreviations</h2><div class="c-article-section__content" id="abbreviations-content"><dl class="c-abbreviation_list"><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMEM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Dulbecco Modified Eagle Medium</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>DMFS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>distant metastasis-free survival</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>ER:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>estrogen receptor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>Flt1:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>vascular endothelial growth factor receptor 1</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>HER2:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>human epidermal growth factor receptor 2</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>IHC:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>immunohistochemistry</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>IPA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>ingenuity pathway analysis</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>JMJD6:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Jumonji domain-containing 6 protein</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>LumA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>luminal A</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>LumB:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>luminal B</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>MCF-7-J1-OE:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>MCF-7 JMJD6 overexpression</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>PTDSR:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>phosphatidylserine receptor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>RT-PCR:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>real-time polymerase chain reaction</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>SPINK1:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>serine protease inhibitor Kazal type 1</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TGF-:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>transforming growth factor-</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>TMA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>tissue microarray</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16"><dfn>U2AF65:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>U2 auxiliary factor 65.</p>
                  </dd></dl></div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1_3001">Soon WWML, Black MA, Dalmasso C, Chan XB, Pang B, Ong CW, Salto-Tellez M, Desai K, Liu ET: <b>Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.</b>
<i>EMBO Mol Med</i> 2011, <b>3:</b>451464.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhtValt7rO" aria-label="CAS reference 1">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2Femmm.201100150" aria-label="Article reference 1">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21656687" aria-label="PubMed reference 1" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377086" aria-label="PubMed Central reference 1" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Combined%20genomic%20and%20phenotype%20screening%20reveals%20secretory%20factor%20SPINK1%20as%20an%20invasion%20and%20survival%20factor%20associated%20with%20patient%20prognosis%20in%20breast%20cancer&amp;journal=EMBO%20Mol%20Med&amp;volume=3&amp;pages=451-464&amp;publication_year=2011&amp;author=Soon%2CWWML&amp;author=Black%2CMA&amp;author=Dalmasso%2CC&amp;author=Chan%2CXB&amp;author=Pang%2CB&amp;author=Ong%2CCW&amp;author=Salto-Tellez%2CM&amp;author=Desai%2CK&amp;author=Liu%2CET">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2_3001">Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RAB, Henson PM: <b>A receptor for phosphatidylserine-specific clearance of apoptotic cells.</b>
<i>Nature</i> 2000, <b>405:</b>8590.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXjt1yitb0%3D" aria-label="CAS reference 2">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F35011084" aria-label="Article reference 2">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10811223" aria-label="PubMed reference 2" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20receptor%20for%20phosphatidylserine-specific%20clearance%20of%20apoptotic%20cells&amp;journal=Nature&amp;volume=405&amp;pages=85-90&amp;publication_year=2000&amp;author=Fadok%2CVA&amp;author=Bratton%2CDL&amp;author=Rose%2CDM&amp;author=Pearson%2CA&amp;author=Ezekewitz%2CRAB&amp;author=Henson%2CPM">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3_3001">Bose J, Gruber A, Helming L, Schiebe S, Wegener I, Hafner M, Beales M, Kontgen F, Lengeling A: <b>The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal.</b>
<i>J Biol</i> 2004, <b>3:</b>15.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fjbiol10" aria-label="Article reference 3">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15345036" aria-label="PubMed reference 3" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC549712" aria-label="PubMed Central reference 3" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20phosphatidylserine%20receptor%20has%20essential%20functions%20during%20embryogenesis%20but%20not%20in%20apoptotic%20cell%20removal&amp;journal=J%20Biol&amp;volume=3&amp;publication_year=2004&amp;author=Bose%2CJ&amp;author=Gruber%2CA&amp;author=Helming%2CL&amp;author=Schiebe%2CS&amp;author=Wegener%2CI&amp;author=Hafner%2CM&amp;author=Beales%2CM&amp;author=Kontgen%2CF&amp;author=Lengeling%2CA">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4_3001">Cui P, Qin B, Liu N, Pan G, Pei D: <b>Nuclear localization of the phosphatidylserine receptor protein via multiple nuclear localization signals.</b>
<i>Exp Cell Res</i> 2004, <b>293:</b>154163.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXjtVeltA%3D%3D" aria-label="CAS reference 4">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.yexcr.2003.09.023" aria-label="Article reference 4">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=14729065" aria-label="PubMed reference 4" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Nuclear%20localization%20of%20the%20phosphatidylserine%20receptor%20protein%20via%20multiple%20nuclear%20localization%20signals&amp;journal=Exp%20Cell%20Res&amp;volume=293&amp;pages=154-163&amp;publication_year=2004&amp;author=Cui%2CP&amp;author=Qin%2CB&amp;author=Liu%2CN&amp;author=Pan%2CG&amp;author=Pei%2CD">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5_3001">Chang B, Chen Y, Zhao Y, Bruick RK: <b>JMJD6 Is a histone arginine demethylase.</b>
<i>Science</i> 2007, <b>318:</b>444447.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtFOjtb%2FE" aria-label="CAS reference 5">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1145801" aria-label="Article reference 5">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17947579" aria-label="PubMed reference 5" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=JMJD6%20Is%20a%20histone%20arginine%20demethylase&amp;journal=Science&amp;volume=318&amp;pages=444-447&amp;publication_year=2007&amp;author=Chang%2CB&amp;author=Chen%2CY&amp;author=Zhao%2CY&amp;author=Bruick%2CRK">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6_3001">Webby CJ, Wolf A, Gromak N, Dreger M, Kramer H, Kessler B, Nielsen ML, Schmitz C, Butler DS, Yates JR, Delahunty CM, Hahn P, Lengeling A, Mann M, Proudfoot NJ, Schofield CJ, Bttger A: <b>Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.</b>
<i>Science</i> 2009, <b>325:</b>9093.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXnvF2kt78%3D" aria-label="CAS reference 6">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1126%2Fscience.1175865" aria-label="Article reference 6">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19574390" aria-label="PubMed reference 6" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Jmjd6%20catalyses%20lysyl-hydroxylation%20of%20U2AF65%2C%20a%20protein%20associated%20with%20RNA%20splicing&amp;journal=Science&amp;volume=325&amp;pages=90-93&amp;publication_year=2009&amp;author=Webby%2CCJ&amp;author=Wolf%2CA&amp;author=Gromak%2CN&amp;author=Dreger%2CM&amp;author=Kramer%2CH&amp;author=Kessler%2CB&amp;author=Nielsen%2CML&amp;author=Schmitz%2CC&amp;author=Butler%2CDS&amp;author=Yates%2CJR&amp;author=Delahunty%2CCM&amp;author=Hahn%2CP&amp;author=Lengeling%2CA&amp;author=Mann%2CM&amp;author=Proudfoot%2CNJ&amp;author=Schofield%2CCJ&amp;author=B%C3%B6ttger%2CA">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7_3001">Boeckel J-N, Guarani V, Koyanagi M, Roexe T, Lengeling A, Schermuly RT, Gellert P, Braun T, Zeiher A, Dimmeler S: <b>Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1.</b>
<i>Proc Natl Acad Sci USA</i> 2011, <b>108:</b>32763281.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXislGhtbo%3D" aria-label="CAS reference 7">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1008098108" aria-label="Article reference 7">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21300889" aria-label="PubMed reference 7" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044381" aria-label="PubMed Central reference 7" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Jumonji%20domain-containing%20protein%206%20%28Jmjd6%29%20is%20required%20for%20angiogenic%20sprouting%20and%20regulates%20splicing%20of%20VEGF-receptor%201&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=108&amp;pages=3276-3281&amp;publication_year=2011&amp;author=Boeckel%2CJ-N&amp;author=Guarani%2CV&amp;author=Koyanagi%2CM&amp;author=Roexe%2CT&amp;author=Lengeling%2CA&amp;author=Schermuly%2CRT&amp;author=Gellert%2CP&amp;author=Braun%2CT&amp;author=Zeiher%2CA&amp;author=Dimmeler%2CS">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8_3001">Hong X, Zang J, White J, Wang C, Pan CH, Zhao R, Murphy RC, Dai S, Henson P, Kappler JW, Hagman J, Zhang G: <b>Interaction of JMJD6 with single-stranded RNA.</b>
<i>Proc Natl Acad Sci USA</i> 2010, <b>107:</b>1456814572.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVOgsLfF" aria-label="CAS reference 8">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1008832107" aria-label="Article reference 8">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20679243" aria-label="PubMed reference 8" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930430" aria-label="PubMed Central reference 8" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Interaction%20of%20JMJD6%20with%20single-stranded%20RNA&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=107&amp;pages=14568-14572&amp;publication_year=2010&amp;author=Hong%2CX&amp;author=Zang%2CJ&amp;author=White%2CJ&amp;author=Wang%2CC&amp;author=Pan%2CCH&amp;author=Zhao%2CR&amp;author=Murphy%2CRC&amp;author=Dai%2CS&amp;author=Henson%2CP&amp;author=Kappler%2CJW&amp;author=Hagman%2CJ&amp;author=Zhang%2CG">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9_3001">Team RDC: <b>R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.</b> 2010.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=R%3A%20a%20language%20and%20environment%20for%20statistical%20computing.%20Vienna%3A%20R%20Foundation%20for%20Statistical%20Computing&amp;publication_year=2010">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10_3001">Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: <b>Bioconductor: open software development for computational biology and bioinformatics.</b>
<i>Genome Biol</i> 2004, <b>5:</b>R80.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fgb-2004-5-10-r80" aria-label="Article reference 10">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15461798" aria-label="PubMed reference 10" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC545600" aria-label="PubMed Central reference 10" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Bioconductor%3A%20open%20software%20development%20for%20computational%20biology%20and%20bioinformatics&amp;journal=Genome%20Biol&amp;volume=5&amp;publication_year=2004&amp;author=Gentleman%2CRC&amp;author=Carey%2CVJ&amp;author=Bates%2CDM&amp;author=Bolstad%2CB&amp;author=Dettling%2CM&amp;author=Dudoit%2CS&amp;author=Ellis%2CB&amp;author=Gautier%2CL&amp;author=Ge%2CY&amp;author=Gentry%2CJ&amp;author=Hornik%2CK&amp;author=Hothorn%2CT&amp;author=Huber%2CW&amp;author=Iacus%2CS&amp;author=Irizarry%2CR&amp;author=Leisch%2CF&amp;author=Li%2CC&amp;author=Maechler%2CM&amp;author=Rossini%2CAJ&amp;author=Sawitzki%2CG&amp;author=Smith%2CC&amp;author=Smyth%2CG&amp;author=Tierney%2CL&amp;author=Yang%2CJY&amp;author=Zhang%2CJ">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11_3001">Li C, Rabinovic A: <b>Adjusting batch effects in microarray expression data using empirical Bayes methods.</b>
<i>Biostatistics</i> 2007, <b>8:</b>118127.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXislOrsw%3D%3D" aria-label="CAS reference 11">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1093%2Fbiostatistics%2Fkxj037" aria-label="Article reference 11">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16632515" aria-label="PubMed reference 11" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Adjusting%20batch%20effects%20in%20microarray%20expression%20data%20using%20empirical%20Bayes%20methods&amp;journal=Biostatistics&amp;volume=8&amp;pages=118-127&amp;publication_year=2007&amp;author=Li%2CC&amp;author=Rabinovic%2CA">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12_3001">Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS: <b>Supervised risk predictor of breast cancer based on intrinsic subtypes.</b>
<i>J Clin Oncol</i> 2009, <b>27:</b>11601167.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1200%2FJCO.2008.18.1370" aria-label="Article reference 12">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19204204" aria-label="PubMed reference 12" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667820" aria-label="PubMed Central reference 12" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Supervised%20risk%20predictor%20of%20breast%20cancer%20based%20on%20intrinsic%20subtypes&amp;journal=J%20Clin%20Oncol&amp;volume=27&amp;pages=1160-1167&amp;publication_year=2009&amp;author=Parker%2CJS&amp;author=Mullins%2CM&amp;author=Cheang%2CMC&amp;author=Leung%2CS&amp;author=Voduc%2CD&amp;author=Vickery%2CT&amp;author=Davies%2CS&amp;author=Fauron%2CC&amp;author=He%2CX&amp;author=Hu%2CZ&amp;author=Quackenbush%2CJF&amp;author=Stijleman%2CIJ&amp;author=Palazzo%2CJ&amp;author=Marron%2CJS&amp;author=Nobel%2CAB&amp;author=Mardis%2CE&amp;author=Nielsen%2CTO&amp;author=Ellis%2CMJ&amp;author=Perou%2CCM&amp;author=Bernard%2CPS">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13_3001">
<b>UNC Microarray Database</b>
[<a href="https://genome.unc.edu/pubsup/breastGEO">https://genome.unc.edu/pubsup/breastGEO</a>]</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14_3001">Prat A, Parker J, Karginova O, Fan C, Livasy C, Herschkowitz J, He X, Perou C: <b>Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.</b>
<i>Breast Cancer Res</i> 2010, <b>12:</b>R68.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fbcr2635" aria-label="Article reference 14">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20813035" aria-label="PubMed reference 14" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096954" aria-label="PubMed Central reference 14" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Phenotypic%20and%20molecular%20characterization%20of%20the%20claudin-low%20intrinsic%20subtype%20of%20breast%20cancer&amp;journal=Breast%20Cancer%20Res&amp;volume=12&amp;publication_year=2010&amp;author=Prat%2CA&amp;author=Parker%2CJ&amp;author=Karginova%2CO&amp;author=Fan%2CC&amp;author=Livasy%2CC&amp;author=Herschkowitz%2CJ&amp;author=He%2CX&amp;author=Perou%2CC">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15_3001">
<i>SigmaPlot for Windows</i> 11.0th edition. Systat Software, Inc., San Jose, CA; 2008.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16_3001">Salto-Tellez M, Nga ME, Han HC, Wong AS, Lee CK, Anuar D, Ng SS, Ho M, Wee A, Chan YH, Soong R: <b>Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours.</b>
<i>Br J Cancer</i> 2007, <b>96:</b>776782.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXisVGisr4%3D" aria-label="CAS reference 16">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2Fsj.bjc.6603551" aria-label="Article reference 16">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17299397" aria-label="PubMed reference 16" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360083" aria-label="PubMed Central reference 16" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Tissue%20microarrays%20characterise%20the%20clinical%20significance%20of%20a%20VEGF-A%20protein%20expression%20signature%20in%20gastrointestinal%20stromal%20tumours&amp;journal=Br%20J%20Cancer&amp;volume=96&amp;pages=776-782&amp;publication_year=2007&amp;author=Salto-Tellez%2CM&amp;author=Nga%2CME&amp;author=Han%2CHC&amp;author=Wong%2CAS&amp;author=Lee%2CCK&amp;author=Anuar%2CD&amp;author=Ng%2CSS&amp;author=Ho%2CM&amp;author=Wee%2CA&amp;author=Chan%2CYH&amp;author=Soong%2CR">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17_3001">Das K, Mohd Omar MF, Ong CW, Bin Abdul Rashid S, Peh BK, Putti TC, Tan PH, Chia KS, Teh M, Shah N, Soong R, Salto-Tellez M: <b>TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.</b>
<i>Pathology</i> 2008, <b>40:</b>441449.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXot1Kls7w%3D" aria-label="CAS reference 17">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1080%2F00313020802198101" aria-label="Article reference 17">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18604728" aria-label="PubMed reference 17" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=TRARESA%3A%20a%20tissue%20microarray-based%20hospital%20system%20for%20biomarker%20validation%20and%20discovery&amp;journal=Pathology&amp;volume=40&amp;pages=441-449&amp;publication_year=2008&amp;author=Das%2CK&amp;author=Mohd%20Omar%2CMF&amp;author=Ong%2CCW&amp;author=Bin%20Abdul%20Rashid%2CS&amp;author=Peh%2CBK&amp;author=Putti%2CTC&amp;author=Tan%2CPH&amp;author=Chia%2CKS&amp;author=Teh%2CM&amp;author=Shah%2CN&amp;author=Soong%2CR&amp;author=Salto-Tellez%2CM">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18_3001">
<i>PASW Statistics 18</i> 18.0.0 edition. Chicago: SPSS Inc.; 2009.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19_3001">Shtutman M, Levina E, Ohouo P, Baig M, Roninson IB: <b>Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.</b>
<i>Cancer Res</i> 2006, <b>66:</b>1137011380.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD28Xht1KnsL3M" aria-label="CAS reference 19">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1158%2F0008-5472.CAN-06-2106" aria-label="Article reference 19">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17145883" aria-label="PubMed reference 19" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Cell%20adhesion%20molecule%20L1%20disrupts%20E-cadherin-containing%20adherens%20junctions%20and%20increases%20scattering%20and%20motility%20of%20MCF7%20breast%20carcinoma%20cells&amp;journal=Cancer%20Res&amp;volume=66&amp;pages=11370-11380&amp;publication_year=2006&amp;author=Shtutman%2CM&amp;author=Levina%2CE&amp;author=Ohouo%2CP&amp;author=Baig%2CM&amp;author=Roninson%2CIB">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20_3001">
<b>Ingenuity Systems</b>
[<a href="http://www.ingenuity.com">http://www.ingenuity.com</a>]</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21_3001">Eisen MB, Spellman PT, Brown PO, Botstein D: <b>Cluster analysis and display of genome-wide expression patterns.</b>
<i>Proc Natl Acad Sci USA</i> 1998, <b>95:</b>1486314868.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1cXotVGmurk%3D" aria-label="CAS reference 21">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.95.25.14863" aria-label="Article reference 21">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9843981" aria-label="PubMed reference 21" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24541" aria-label="PubMed Central reference 21" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Cluster%20analysis%20and%20display%20of%20genome-wide%20expression%20patterns&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=95&amp;pages=14863-14868&amp;publication_year=1998&amp;author=Eisen%2CMB&amp;author=Spellman%2CPT&amp;author=Brown%2CPO&amp;author=Botstein%2CD">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22_3001">Eisen M: <i>TreeView</i>. 1.60th edition. 2002.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=TreeView&amp;publication_year=2002&amp;author=Eisen%2CM">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23_3001">Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM: <b>Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.</b>
<i>Genome Biol</i> 2007, <b>8:</b>R76.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1186%2Fgb-2007-8-5-r76" aria-label="Article reference 23">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17493263" aria-label="PubMed reference 23" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929138" aria-label="PubMed Central reference 23" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20conserved%20gene%20expression%20features%20between%20murine%20mammary%20carcinoma%20models%20and%20human%20breast%20tumors&amp;journal=Genome%20Biol&amp;volume=8&amp;publication_year=2007&amp;author=Herschkowitz%2CJI&amp;author=Simin%2CK&amp;author=Weigman%2CVJ&amp;author=Mikaelian%2CI&amp;author=Usary%2CJ&amp;author=Hu%2CZ&amp;author=Rasmussen%2CKE&amp;author=Jones%2CLP&amp;author=Assefnia%2CS&amp;author=Chandrasekharan%2CS&amp;author=Backlund%2CMG&amp;author=Yin%2CY&amp;author=Khramtsov%2CAI&amp;author=Bastein%2CR&amp;author=Quackenbush%2CJ&amp;author=Glazer%2CRI&amp;author=Brown%2CPH&amp;author=Green%2CJE&amp;author=Kopelovich%2CL&amp;author=Furth%2CPA&amp;author=Palazzo%2CJP&amp;author=Olopade%2COI&amp;author=Bernard%2CPS&amp;author=Churchill%2CGA&amp;author=Van%20Dyke%2CT&amp;author=Perou%2CCM">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24_3001">Srlie T: <b>Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.</b>
<i>Eur J Cancer</i> 2004, <b>40:</b>26672675.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2Fj.ejca.2004.08.021" aria-label="Article reference 24">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15571950" aria-label="PubMed reference 24" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20portraits%20of%20breast%20cancer%3A%20tumour%20subtypes%20as%20distinct%20disease%20entities&amp;journal=Eur%20J%20Cancer&amp;volume=40&amp;pages=2667-2675&amp;publication_year=2004&amp;author=S%C3%B8rlie%2CT">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25_3001">Moses HL: <b>TGF-beta regulation of epithelial cell proliferation.</b>
<i>Mol Reprod Dev</i> 1992, <b>32:</b>179184.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK38XltVCgtrc%3D" aria-label="CAS reference 25">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2Fmrd.1080320215" aria-label="Article reference 25">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1637556" aria-label="PubMed reference 25" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=TGF-beta%20regulation%20of%20epithelial%20cell%20proliferation&amp;journal=Mol%20Reprod%20Dev&amp;volume=32&amp;pages=179-184&amp;publication_year=1992&amp;author=Moses%2CHL">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26_3001">Robson CN, Gnanapragasam V, Byrne RL, Collins AT, Neal DE: <b>Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium.</b>
<i>J Endocrinol</i> 1999, <b>160:</b>257266.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1MXjs12rsbc%3D" aria-label="CAS reference 26">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1677%2Fjoe.0.1600257" aria-label="Article reference 26">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9924195" aria-label="PubMed reference 26" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20growth%20factor-beta1%20up-regulates%20p15%2C%20p21%20and%20p27%20and%20blocks%20cell%20cycling%20in%20G1%20in%20human%20prostate%20epithelium&amp;journal=J%20Endocrinol&amp;volume=160&amp;pages=257-266&amp;publication_year=1999&amp;author=Robson%2CCN&amp;author=Gnanapragasam%2CV&amp;author=Byrne%2CRL&amp;author=Collins%2CAT&amp;author=Neal%2CDE">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27_3001">Ravitz MJWC: <b>Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.</b>
<i>Adv Cancer Res</i> 1997, <b>71:</b>165207.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2sXjvVOkuro%3D" aria-label="CAS reference 27">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0065-230X%2808%2960099-8" aria-label="Article reference 27">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9111866" aria-label="PubMed reference 27" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin-dependent%20kinase%20regulation%20during%20G1%20phase%20and%20cell%20cycle%20regulation%20by%20TGF-beta&amp;journal=Adv%20Cancer%20Res&amp;volume=71&amp;pages=165-207&amp;publication_year=1997&amp;author=Ravitz%2CMJWC">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28_3001">Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM, Forbes JT: <b>Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.</b>
<i>J Clin Invest</i> 1993, <b>92:</b>25692576.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXltFCnsQ%3D%3D" aria-label="CAS reference 28">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1172%2FJCI116871" aria-label="Article reference 28">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7504687" aria-label="PubMed reference 28" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC288452" aria-label="PubMed Central reference 28" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Anti-transforming%20growth%20factor%20%28TGF%29-beta%20antibodies%20inhibit%20breast%20cancer%20cell%20tumorigenicity%20and%20increase%20mouse%20spleen%20natural%20killer%20cell%20activity%3A%20implications%20for%20a%20possible%20role%20of%20tumor%20cell%2Fhost%20TGF-beta%20interactions%20in%20human%20breast%20cancer%20progression&amp;journal=J%20Clin%20Invest&amp;volume=92&amp;pages=2569-2576&amp;publication_year=1993&amp;author=Arteaga%2CCL&amp;author=Hurd%2CSD&amp;author=Winnier%2CAR&amp;author=Johnson%2CMD&amp;author=Fendly%2CBM&amp;author=Forbes%2CJT">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29_3001">Ji H, Stout LE, Zhang Q, Zhang R, Leung HT, Leung BS: <b>Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.</b>
<i>J Cell Biochem</i> 1994, <b>54:</b>332342.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXitVyis7o%3D" aria-label="CAS reference 29">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1002%2Fjcb.240540309" aria-label="Article reference 29">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8200913" aria-label="PubMed reference 29" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Absence%20of%20transforming%20growth%20factor-beta%20responsiveness%20in%20the%20tamoxifen%20growth-inhibited%20human%20breast%20cancer%20cell%20line%20CAMA-1&amp;journal=J%20Cell%20Biochem&amp;volume=54&amp;pages=332-342&amp;publication_year=1994&amp;author=Ji%2CH&amp;author=Stout%2CLE&amp;author=Zhang%2CQ&amp;author=Zhang%2CR&amp;author=Leung%2CHT&amp;author=Leung%2CBS">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30_3001">Fanayan S, Firth SM, Butt AJ, Baxter RC: <b>Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-(TGF-) and the type II TGF- receptor.</b>
<i>J Biol Chem</i> 2000, <b>275:</b>3914639151.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXptFSrsro%3D" aria-label="CAS reference 30">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1074%2Fjbc.M006964200" aria-label="Article reference 30">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10993898" aria-label="PubMed reference 30" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Growth%20inhibition%20by%20insulin-like%20growth%20factor-binding%20protein-3%20in%20T47D%20breast%20cancer%20cells%20requires%20transforming%20growth%20factor-%CE%B2%28TGF-%CE%B2%29%20and%20the%20type%20II%20TGF-%CE%B2%20receptor&amp;journal=J%20Biol%20Chem&amp;volume=275&amp;pages=39146-39151&amp;publication_year=2000&amp;author=Fanayan%2CS&amp;author=Firth%2CSM&amp;author=Butt%2CAJ&amp;author=Baxter%2CRC">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31_3001">Chen CR, Kang Y, Massagu J: <b>Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor  growth arrest program.</b>
<i>Proc Natl Acad Sci USA</i> 2001, <b>98:</b>992999.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXht1Sms7Y%3D" aria-label="CAS reference 31">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.98.3.992" aria-label="Article reference 31">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11158583" aria-label="PubMed reference 31" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC14697" aria-label="PubMed Central reference 31" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Defective%20repression%20of%20c-myc%20in%20breast%20cancer%20cells%3A%20a%20loss%20at%20the%20core%20of%20the%20transforming%20growth%20factor%20%CE%B2%20growth%20arrest%20program&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=98&amp;pages=992-999&amp;publication_year=2001&amp;author=Chen%2CCR&amp;author=Kang%2CY&amp;author=Massagu%C3%A9%2CJ">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32_3001">Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T: <b>TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.</b>
<i>Development</i> 1997, <b>124:</b>26592670.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2sXks1artbk%3D" aria-label="CAS reference 32">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9217007" aria-label="PubMed reference 32" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850286" aria-label="PubMed Central reference 32" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=TGFbeta2%20knockout%20mice%20have%20multiple%20developmental%20defects%20that%20are%20non-overlapping%20with%20other%20TGFbeta%20knockout%20phenotypes&amp;journal=Development&amp;volume=124&amp;pages=2659-2670&amp;publication_year=1997&amp;author=Sanford%2CLP&amp;author=Ormsby%2CI&amp;author=Gittenberger-de%20Groot%2CAC&amp;author=Sariola%2CH&amp;author=Friedman%2CR&amp;author=Boivin%2CGP&amp;author=Cardell%2CEL&amp;author=Doetschman%2CT">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33_3001">Geng Y, Weinberg RA: <b>Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.</b>
<i>Proc Natl Acad Sci USA</i> 1993, <b>90:</b>1031510319.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2cXks1GmtA%3D%3D" aria-label="CAS reference 33">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.90.21.10315" aria-label="Article reference 33">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7694291" aria-label="PubMed reference 33" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC47765" aria-label="PubMed Central reference 33" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20growth%20factor%20beta%20effects%20on%20expression%20of%20G1%20cyclins%20and%20cyclin-dependent%20protein%20kinases&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=90&amp;pages=10315-10319&amp;publication_year=1993&amp;author=Geng%2CY&amp;author=Weinberg%2CRA">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34_3001">Moustakas A, Pardali K, Gaal A, Heldin C-H: <b>Mechanisms of TGF-[beta] signaling in regulation of cell growth and differentiation.</b>
<i>Immunol Lett</i> 2002, <b>82:</b>8591.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XjsVSqu7w%3D" aria-label="CAS reference 34">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1016%2FS0165-2478%2802%2900023-8" aria-label="Article reference 34">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12008039" aria-label="PubMed reference 34" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20TGF-%5Bbeta%5D%20signaling%20in%20regulation%20of%20cell%20growth%20and%20differentiation&amp;journal=Immunol%20Lett&amp;volume=82&amp;pages=85-91&amp;publication_year=2002&amp;author=Moustakas%2CA&amp;author=Pardali%2CK&amp;author=Gaal%2CA&amp;author=Heldin%2CC-H">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35_3001">Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF: <b>Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.</b>
<i>Proc Natl Acad Sci USA</i> 1995, <b>92:</b>55455549.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK2MXmtFOgsLo%3D" aria-label="CAS reference 35">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.92.12.5545" aria-label="Article reference 35">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7777546" aria-label="PubMed reference 35" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC41732" aria-label="PubMed Central reference 35" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Transforming%20growth%20factor%20beta%20induces%20the%20cyclin-dependent%20kinase%20inhibitor%20p21%20through%20a%20p53-independent%20mechanism&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=92&amp;pages=5545-5549&amp;publication_year=1995&amp;author=Datto%2CMB&amp;author=Li%2CY&amp;author=Panus%2CJF&amp;author=Howe%2CDJ&amp;author=Xiong%2CY&amp;author=Wang%2CXF">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36_3001">Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS: <b>Cyclin E and survival in patients with breast cancer.</b>
<i>N Engl J Med</i> 2002, <b>347:</b>15661575.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BD38Xos1KhsLo%3D" aria-label="CAS reference 36">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1056%2FNEJMoa021153" aria-label="Article reference 36">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12432043" aria-label="PubMed reference 36" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20E%20and%20survival%20in%20patients%20with%20breast%20cancer&amp;journal=N%20Engl%20J%20Med&amp;volume=347&amp;pages=1566-1575&amp;publication_year=2002&amp;author=Keyomarsi%2CK&amp;author=Tucker%2CSL&amp;author=Buchholz%2CTA&amp;author=Callister%2CM&amp;author=Ding%2CY&amp;author=Hortobagyi%2CGN&amp;author=Bedrosian%2CI&amp;author=Knickerbocker%2CC&amp;author=Toyofuku%2CW&amp;author=Lowe%2CM&amp;author=Herliczek%2CTW&amp;author=Bacus%2CSS">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37_3001">Spruck CH, Won K-A, Reed SI: <b>Deregulated cyclin E induces chromosome instability.</b>
<i>Nature</i> 1999, <b>401:</b>297300.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DyaK1MXmt1yrsr8%3D" aria-label="CAS reference 37">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1038%2F45836" aria-label="Article reference 37">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10499591" aria-label="PubMed reference 37" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Deregulated%20cyclin%20E%20induces%20chromosome%20instability&amp;journal=Nature&amp;volume=401&amp;pages=297-300&amp;publication_year=1999&amp;author=Spruck%2CCH&amp;author=Won%2CK-A&amp;author=Reed%2CSI">
                    Google Scholar</a>
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38_3001">Scaltriti M, Eichhorn PJ, Corts J, Prudkin L, Aura C, Jimnez J, Chandarlapaty S, Serra V, Prat A, Ibrahim YH, Guzmn M, Gili M, Rodrguez O, Rodrguez S, Prez J, Green SR, Mai S, Rosen N, Hudis C, Baselga J: <b>Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.</b>
<i>Proc Natl Acad Sci USA</i> 2011, <b>108:</b>37613766.</p><p class="c-article-references__links u-hide-print"><a data-track="click" data-track-action="outbound reference" data-track-label="link" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXivFOltLY%3D" aria-label="CAS reference 38">CAS</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="https://doi.org/10.1073%2Fpnas.1014835108" aria-label="Article reference 38">Article</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21321214" aria-label="PubMed reference 38" rel="nofollow">PubMed</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048107" aria-label="PubMed Central reference 38" rel="nofollow">PubMed Central</a>
    <a data-track="click" data-track-action="outbound reference" data-track-label="link" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Cyclin%20E%20amplification%2Foverexpression%20is%20a%20mechanism%20of%20trastuzumab%20resistance%20in%20HER2%2B%20breast%20cancer%20patients&amp;journal=Proc%20Natl%20Acad%20Sci%20USA&amp;volume=108&amp;pages=3761-3766&amp;publication_year=2011&amp;author=Scaltriti%2CM&amp;author=Eichhorn%2CPJ&amp;author=Cort%C3%A9s%2CJ&amp;author=Prudkin%2CL&amp;author=Aura%2CC&amp;author=Jim%C3%A9nez%2CJ&amp;author=Chandarlapaty%2CS&amp;author=Serra%2CV&amp;author=Prat%2CA&amp;author=Ibrahim%2CYH&amp;author=Guzm%C3%A1n%2CM&amp;author=Gili%2CM&amp;author=Rodr%C3%ADguez%2CO&amp;author=Rodr%C3%ADguez%2CS&amp;author=P%C3%A9rez%2CJ&amp;author=Green%2CSR&amp;author=Mai%2CS&amp;author=Rosen%2CN&amp;author=Hudis%2CC&amp;author=Baselga%2CJ">
                    Google Scholar</a>
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" href="https://citation-needed.springer.com/v2/references/10.1186/bcr3200?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>This work was funded by the Agency for Science, Technology and Research (A*STAR) of Singapore. YFL is a recipient of the A*STAR Graduate Scholarship. We thank Keith Rogers, Susan Rogers, and Hassan Hall of the Histology Department for immunohistochemical staining, the Confocal and High Content Screening facility of Basement Shared Facilities (BSF), and the Agency of Science, Technology and Research (A*STAR) for their services. We thank Dr Paturu Kondaiah, Indian Institute of Science, Bangalore, India, for useful discussions.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Department of Cancer Biology and Pharmacology, Genome Institute of Singapore, 60 Biopolis Street, Genome Building, Kragujevac, 138672, Singapore</p><p class="c-article-author-affiliation__authors-list">Yi Fang Lee,Xiu Bin Chan&amp;Edison T Liu</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA</p><p class="c-article-author-affiliation__authors-list">Lance David Miller</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Department of Pathology, National University Health System and National University of Singapore, 5 Lower Kent Ridge Road, Kragujevac, 119074, Singapore</p><p class="c-article-author-affiliation__authors-list">Brendan Pang&amp;Chee Wee Ong</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Centre for Cancer Research and Cell Biology, Queens University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK</p><p class="c-article-author-affiliation__authors-list">Manuel Salto-Tellez</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Cancer Science Institute, National University of Singapore, 28 Medical Drive, Kragujevac, 117456, Singapore</p><p class="c-article-author-affiliation__authors-list">Manuel Salto-Tellez</p></li><li id="Aff6"><p class="c-article-author-affiliation__address">Department of Biochemistry, Otago School of Medical Sciences, University of Otago, 710 Cumberland Street, Dunedin, 9054, New Zealand</p><p class="c-article-author-affiliation__authors-list">Michael A Black</p></li><li id="Aff7"><p class="c-article-author-affiliation__address">The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, 04609, USA</p><p class="c-article-author-affiliation__authors-list">Edison T Liu</p></li><li id="Aff8"><p class="c-article-author-affiliation__address">National Institute of Biomedical Genomics, 2nd Floor Netaji Subash Sanatorium, Kalyani, 741251, India</p><p class="c-article-author-affiliation__authors-list">Kartiki V Desai</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Yi_Fang-Lee"><span class="c-article-authors-search__title u-h3 js-search-name">Yi Fang Lee</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Yi%20Fang%20Lee%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Yi%20Fang%20Lee" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Yi%20Fang%20Lee%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Lance_David-Miller"><span class="c-article-authors-search__title u-h3 js-search-name">Lance David Miller</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Lance%20David%20Miller%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Lance%20David%20Miller" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Lance%20David%20Miller%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Xiu_Bin-Chan"><span class="c-article-authors-search__title u-h3 js-search-name">Xiu Bin Chan</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Xiu%20Bin%20Chan%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Xiu%20Bin%20Chan" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Xiu%20Bin%20Chan%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Michael_A-Black"><span class="c-article-authors-search__title u-h3 js-search-name">Michael A Black</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Michael%20A%20Black%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Michael%20A%20Black" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Michael%20A%20Black%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Brendan-Pang"><span class="c-article-authors-search__title u-h3 js-search-name">Brendan Pang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Brendan%20Pang%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Brendan%20Pang" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Brendan%20Pang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Chee_Wee-Ong"><span class="c-article-authors-search__title u-h3 js-search-name">Chee Wee Ong</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Chee%20Wee%20Ong%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Chee%20Wee%20Ong" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Chee%20Wee%20Ong%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Manuel-Salto_Tellez"><span class="c-article-authors-search__title u-h3 js-search-name">Manuel Salto-Tellez</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Manuel%20Salto-Tellez%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Manuel%20Salto-Tellez" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Manuel%20Salto-Tellez%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Edison_T-Liu"><span class="c-article-authors-search__title u-h3 js-search-name">Edison T Liu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Edison%20T%20Liu%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Edison%20T%20Liu" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Edison%20T%20Liu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li><li id="auth-Kartiki_V-Desai"><span class="c-article-authors-search__title u-h3 js-search-name">Kartiki V Desai</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="https://www.biomedcentral.com/search?query=author%23%22Kartiki%20V%20Desai%22" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text">You can also search for this author in
                        <span class="c-article-identifiers"><a class="c-article-identifiers__item" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Kartiki%20V%20Desai" data-track="click" data-track-action="author link - pubmed" data-track-label="link">PubMed</a><span class="u-hide"></span><a class="c-article-identifiers__item" href="http://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Kartiki%20V%20Desai%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:kd1@nibmg.ac.in">Kartiki V Desai</a>.</p></div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><h3 class="c-article__sub-heading">Competing interests</h3><p>The authors declare that they have no competing interests.</p><h3 class="c-article__sub-heading">Authors' contributions</h3><p>This study was designed and written by KVD, ETL, and YFL. YFL performed all experiments with assistance from XBC. Breast cohort analysis was done by LDM, YFL, and MAB. BP, CWO, and MST provided the NUH tissue arrays and performed and scored the immunostaining. All authors read and approved the final manuscript.</p><p>An erratum to this article can be found under doi <a href="https://doi.org/10.1186/s13058-017-0830-9">http://dx.doi.org/10.1186/s13058-017-0830-9</a>.
</p></div></div></section><section data-title="Electronic supplementary material"><div class="c-article-section" id="SecESM1_3001-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="SecESM1_3001">Electronic supplementary material</h2><div class="c-article-section__content" id="SecESM1_3001-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div>
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                  
                <div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM1_ESM.XLSX" data-supp-info-image="">Additional file 1: <b>Table S1. QPCR Primers</b>. QPCR primer sequences used in the RT-PCR. (XLSX 12 KB)</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM2_ESM.XLSX" data-supp-info-image="">13058_2011_3001_MOESM2_ESM.XLSX</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 2: <b>Table S2. Microarray datasets</b>. List of clinical microarray datasets used in the survival analysis of <i>JMJD6</i> and their general information, including database source and literature references. (XLSX 10 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM3_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM3_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 3: <b>Figure S1. Upper-quartile expression of</b>
<b><i>JMJD6</i></b>
<b>is associated with poor survival in LumA and LumB subtypes</b>. Kaplan-Meier survival curves were generated based on quartile ranking of <i>JMJD6</i> expression within the individual subtype. Representative images are shown for <b>(A)</b> LumA subtype and <b>(B)</b> LumB subtype. *Log rank <i>P</i> &lt; 0.05; #log rank <i>P</i> &lt; 0.001 between two quartile expression groups within the subtype. (PDF 129 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM4_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM4_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 4: <b>Figure S2. Standardization of JMJD6 immunohistochemistry</b>. IHC for JMJD6 was performed on wild-type (left panel), <i>JMJD6</i> siRNA-mediated knockdown (middle panel), and JMJD6-overexpressing (right panel) MCF-7 cells. As shown in the figure, wild-type and <i>JMJD6</i> siRNA cells showed low to negligible amounts of immunoreactivity, whereas expression of JMJD6 was the highest in MCF7-J1-OE cells. (PDF 159 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM5_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM5_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 5: <b>Figure S3. Protein expression and knockdown of JMJD6 in other cell lines. (A)</b> Western blot of different breast cancer cell lines suggests that JMJD6 protein expression was low in MCF-7, whereas MDA-MB231, T47D, CAMA-1, and BT-549 cells harbored substantial amounts of JMJD6 protein. <b>(B)</b> Level of apoptosis in cells transfected with <i>JMJD6</i> siRNA was determined by using a PARP-cleavage assay. Bar chart shows that the percentage of cells with cleaved PARP was similar in both <i>JMJD6</i> siRNA and scrambled siRNA-transfected MCF-7 cells. <b>(C)</b> Decreased proliferation was observed in BT-549, CAMA-1, and T47D when JMJD6 was knocked down by three individual JMJD6-specific siRNAs after 4 days of plating, as compared with the scrambled siRNA control (Sc siRNA); <i>P</i>  0.005. Error bars represent standard deviation. (PDF 73 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM6_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM6_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 6: <b>Figure S4. Pooled population of MCF-7 J1-OE cells showed increased proliferation and decreased TGF-2 levels. (A)</b> WST-1 assay using MCF-7 J1-OE pooled population before clonal selection showed increased proliferation over vector control cells (Vec). <b>(B)</b> Immunoblots of conditioned media showed decreased levels of secreted TGF-2 in MCF-7 J1-OE pooled population as compared with Vec. NS, nonspecific bands from the same TGF-2 antibody blot to indicate even total protein loading. (PDF 621 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM7_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM7_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 7: <b>Figure S5. Overexpression of JMJD6 in CAMA, T47D, and MDA-MB231 had no effect on proliferation</b>. Figures (top panel) show Western blot for V5-tagged JMJD6 clones expressed in <b>(A)</b> CAMA, <b>(B)</b> T47D, and <b>(C)</b> MDA-MB231, respectively, and -actin as an internal control for loading. A through C (bottom) show that stable <i>JMJD6</i> overexpression clones did not display increased proliferation as compared with the Vec control. (PDF 75 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM8_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM8_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 8: <b>Figure S6. MCF-7 J1-OE cells did not show changes in E-cadherin and vimentin levels</b>. Immunoblots showed that the expression of E-cadherin is similar in the MCF-7 J1-OE cells and Vec cells. Vimentin remained unexpressed in MCF-7 J1-OE cells. MDA-MB231 was used as a positive control for the vimentin antibody. (PDF 33 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM9_ESM.XLSX" data-supp-info-image="">13058_2011_3001_MOESM9_ESM.XLSX</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 9: <b>Table S3. Microarray analysis</b>. List of genes that were differentially expressed by microarray analysis of MCF-7 J1-OE clones and JMJD6 siRNA knockdown cells. (XLSX 266 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM10"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM10_ESM.XLSX" data-supp-info-image="">13058_2011_3001_MOESM10_ESM.XLSX</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 10: <b>Table S4. JMJD6 and gene function</b>. Top ten functions enriched in JMJD6-induced and JMJD6-repressed gene sets by IPA functional analysis and the list of genes in each function. (XLSX 17 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM11"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM11_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM11_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 11: <b>Figure S7. SB431542 does not rescue JMJD6 siRNA-mediated loss of proliferation in MDA-MB231. (A)</b> Immunoblots showed that treatment of rhTGF-2 in MDA-MB231 resulted in enhanced SMAD2 phosphorylation, which could be nullified by SB431542 treatment. <b>(B)</b>
<i>JMJD6</i> siRNA-mediated decreased proliferation of MDA-MB231 could not be rescued by SB431542 (10 <i>M</i>) treatment, as assessed with WST-1 OD measurement. (PDF 152 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM12"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM12_ESM.PDF" data-supp-info-image="">13058_2011_3001_MOESM12_ESM.PDF</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 12: <b>Figure S8. Functional annotation of differentially expressed genes unique to MDA-MB 231 cells transfected with</b>
<b><i>JMJD6</i></b>
<b>siRNA</b>. Bar chart shows IPA functional annotation analysis of differentially expressed genes in MDA-MB231 <i>JMJD6</i> siRNA-mediated knockdown showed significant enrichment of genes involved in cellular death, growth, and movement. Log <i>P</i>-value on the X-axis is Fisher Exact test on the overlap of our gene list and the functional category (Additional File <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/10.1186/bcr3200#MOESM13">13</a>, Table S5). (PDF 102 KB)</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM13"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-track-label="link" data-test="supp-info-link" href="https://static-content.springer.com/esm/art%3A10.1186%2Fbcr3200/MediaObjects/13058_2011_3001_MOESM13_ESM.XLS" data-supp-info-image="">13058_2011_3001_MOESM13_ESM.XLS</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Additional file 13: <b>Table S5. "Proliferation" genes differentially expressed in MDA-MB231</b>. List of genes found in subcategories under the functional annotation for cellular growth and proliferation that were significantly enriched (<i>P</i> &lt; 0.05). The <i>P</i> value is from the Fisher Exact test for the overlap of our dataset and the function. The predicted activation state is stated for significant direction of change (Z score, -2). (XLS 28 KB)</p></div></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content"><p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=JMJD6%20is%20a%20driver%20of%20cellular%20proliferation%20and%20motility%20and%20a%20marker%20of%20poor%20prognosis%20in%20breast%20cancer&amp;author=Yi%20Fang%20Lee%20et%20al&amp;contentID=10.1186%2Fbcr3200&amp;copyright=Desai%20et%20al.%3B%20licensee%20BioMed%20Central%20Ltd.&amp;publication=1465-542X&amp;publicationDate=2012-05-23&amp;publisherName=SpringerNature&amp;orderBeanReset=true">Reprints and Permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Lee, Y.F., Miller, L.D., Chan, X.B. <i>et al.</i> JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
                    <i>Breast Cancer Res</i> <b>14, </b>3001 (2012). https://doi.org/10.1186/bcr3200</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" href="https://citation-needed.springer.com/v2/references/10.1186/bcr3200?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#global-icon-download"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2011-08-20">20 August 2011</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Revised<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-05-05">05 May 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-05-23">23 May 2012</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2012-05-23">23 May 2012</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--doi"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1186/bcr3200</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span>Breast Cancer</span></li><li class="c-article-subject-list__subject"><span>Ingenuity Pathway Analysis</span></li><li class="c-article-subject-list__subject"><span>Intrinsic Subtype</span></li><li class="c-article-subject-list__subject"><span>Dulbecco Modify Eagle Medium</span></li><li class="c-article-subject-list__subject"><span>Smad Phosphorylation</span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>

                    


                </article>
            </main>

            <div class="c-article-extras u-text-sm u-hide-print" data-track-component="reading companion">
                <aside>
                    
    <div class="c-pdf-download u-clear-both">
        <a href="//breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr3200.pdf" class="c-pdf-download__link" data-article-pdf="true"  data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="click" data-track-action="download pdf" data-track-label="link" data-track-external>
            <span>Download PDF</span>
            <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#global-icon-download"/></svg>
        </a>
    </div>

                    

                    
    


                    <div class="c-reading-companion">
                        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
                            <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                                <div class="js-ad">
    
    <aside class="adsbox c-ad c-ad--300x250 u-mt-16" data-component-mpu>
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-MPU1"
                data-ad-type="MPU1"
                data-pa11y-ignore
                data-gpt
                data-gpt-unitpath="/270604982/bmc/breast-cancer-research/articles"
                data-gpt-sizes="300x250"
                data-gpt-targeting="pos=MPU1;doi=10.1186/bcr3200;type=article;kwrd=Breast Cancer,Ingenuity Pathway Analysis,Intrinsic Subtype,Dulbecco Modify Eagle Medium,Smad Phosphorylation;pmc=B11001,H33160,H59150;"
            >
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/bcr3200&amp;type=article&amp;kwrd=Breast Cancer,Ingenuity Pathway Analysis,Intrinsic Subtype,Dulbecco Modify Eagle Medium,Smad Phosphorylation&amp;pmc=B11001,H33160,H59150&amp;">
                        <img data-test="gpt-advert-fallback-img"
                            src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/breast-cancer-research/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/bcr3200&amp;type=article&amp;kwrd=Breast Cancer,Ingenuity Pathway Analysis,Intrinsic Subtype,Dulbecco Modify Eagle Medium,Smad Phosphorylation&amp;pmc=B11001,H33160,H59150&amp;"
                            alt="Advertisement"
                            width="300"
                            height="250">
                    </a>
                </noscript>
            </div>
        </div>
    </aside>
</div>
                            </div>
                            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
                            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
                        </div>
                    </div>
                </aside>
            </div>

        </div>


        
            <div class="c-journal-footer">
                <div class="c-journal-footer__inner">
                    <div class="c-journal-footer__summary">
                        <h4 class="c-journal-title c-journal-title--footer">
                            
                            <span class="c-journal-title__text">Breast Cancer Research</span>
                        </h4>
                         <p class="c-journal-footer__issn">ISSN: 1465-542X</p>
                    </div>
                    
                        <div class="c-journal-footer__contact">
                            <h4 class="c-journal-footer__contact-title ">Contact us</h4>
                            <ul class="c-journal-footer__contact-list">
                                
                                    <li class="c-journal-footer__contact-item">Submission enquiries: <a href="mailto:maritess.reyes@springernature.com">maritess.reyes@springernature.com</a></li>
                                
                                
                                    <li class="c-journal-footer__contact-item">General enquiries: <a href="mailto:info@biomedcentral.com">info@biomedcentral.com</a></li>
                                
                            </ul>
                        </div>
                    
                </div>
            </div>
        
        
    <img rel="nofollow" class='tracker' style='display:none' src='/track/article/10.1186/bcr3200' alt=""/>

         
    <footer>
        
            <div class="c-publisher-footer" data-test="publisher-footer">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between" data-test="publisher-footer-menu">
            <div class="u-display-flex">
                
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://blogs.biomedcentral.com/">Read more on our blogs</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/login">Receive BMC newsletters</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/account">Manage article alerts</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://authorservices.springernature.com/go/10BMC">Language editing for authors</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="http://authorservices.springernature.com/scientific-editing/">Scientific editing for authors</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/policies">Policies</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/accessibility">Accessibility</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/press-centre">Press center</a>
                                </li>
                            
                        </ul>
                    
                        <ul class="c-list-group c-list-group--sm u-mr-24 u-mb-16">
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://support.biomedcentral.com/support/home">Support and Contact</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="https://biomedcentral.typeform.com/to/VLXboo">Leave feedback</a>
                                </li>
                            
                                <li class="c-list-group__item">
                                    <a class="u-gray-link" href="//www.biomedcentral.com/about/jobs">Careers</a>
                                </li>
                            
                        </ul>
                    
                
            </div>
            <div class="u-mb-24">
                <h3 id="social-menu" class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
                <ul class="u-display-flex u-list-reset" data-test="footer-social-links">
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="https://twitter.com/biomedcentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Twitter"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Twitter page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-twitter-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="https://www.facebook.com/BioMedCentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Facebook"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Facebook page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-facebook-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                        <li class="u-mt-8 u-mr-8">
                            <a href="http://www.weibo.com/biomedcentral"
                               data-track="click"
                               data-track-category="Social"
                               data-track-action="Clicked BMC Weibo"
                               class="u-gray-link">
                                <span class="u-visually-hidden">BMC Weibo page</span>
                                <svg class="u-icon u-text-lg" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-weibo-bordered"></use>
                                </svg>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </div>
        <p class="u-reset-margin">
            By using this website, you agree to our
            <a class="u-gray-link" href="//www.biomedcentral.com/terms-and-conditions">Terms and Conditions</a>,
            <a class="u-gray-link" href="https://www.springernature.com/ccpa">California Privacy Statement</a>,
            <a class="u-gray-link" href="//www.biomedcentral.com/privacy-statement">Privacy
                statement</a> and
            <a class="u-gray-link" href="//www.biomedcentral.com/cookies" data-test="cookie-link">Cookies</a> policy.
            
                <a class="optanon-toggle-display u-gray-link" data-cc-action="preferences" href="javascript:void(0);">Manage cookies/Do not sell my data</a> we use in the preference centre.
            
        </p>
    </div>
</div>

        
        <div class="c-corporate-footer">
    <div class="u-container">
        <img src=/static/images/logo-springernature-acb40b85fb.svg class="c-corporate-footer__logo" alt="Springer Nature" itemprop="logo" role="img">
        <p class="c-corporate-footer__legal" data-test="copyright"> &#169; 2022 BioMed Central Ltd unless otherwise stated. Part of
            <a class="c-corporate-footer__link" href="https://www.springernature.com" itemscope itemtype="http://schema.org/Organization" itemid="#parentOrganization">Springer Nature</a>.
        </p>
    </div>
</div>

    </footer>

    </div>



        
    <svg class="u-hide hide">
        <symbol id="global-icon-chevron-right" viewBox="0 0 16 16">
            <path d="M7.782 7L5.3 4.518c-.393-.392-.4-1.022-.02-1.403a1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L7.782 9l1.013-.998z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-download" viewBox="0 0 16 16">
            <path d="M2 14c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H3.002A1.006 1.006 0 012 14zM9 2v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L3.115 7.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L7 8.8V2c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-email" viewBox="0 0 18 18">
            <path d="M1.995 2h14.01A2 2 0 0118 4.006v9.988A2 2 0 0116.005 16H1.995A2 2 0 010 13.994V4.006A2 2 0 011.995 2zM1 13.994A1 1 0 001.995 15h14.01A1 1 0 0017 13.994V4.006A1 1 0 0016.005 3H1.995A1 1 0 001 4.006zM9 11L2 7V5.557l7 4 7-4V7z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-institution" viewBox="0 0 18 18">
            <path d="M14 8a1 1 0 011 1v6h1.5a.5.5 0 01.5.5v.5h.5a.5.5 0 01.5.5V18H0v-1.5a.5.5 0 01.5-.5H1v-.5a.5.5 0 01.5-.5H3V9a1 1 0 112 0v6h8V9a1 1 0 011-1zM6 8l2 1v4l-2 1zm6 0v6l-2-1V9zM9.573.401l7.036 4.925A.92.92 0 0116.081 7H1.92a.92.92 0 01-.528-1.674L8.427.401a1 1 0 011.146 0zM9 2.441L5.345 5h7.31z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="global-icon-search" viewBox="0 0 22 22">
            <path fill-rule="evenodd" d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z"/>
        </symbol>
        <symbol id="icon-info" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-success" viewBox="0 0 18 18">
            <path d="M9 0a9 9 0 110 18A9 9 0 019 0zm3.486 4.982l-4.718 5.506L5.14 8.465a.991.991 0 00-1.423.133 1.06 1.06 0 00.13 1.463l3.407 2.733a1 1 0 001.387-.133l5.385-6.334a1.06 1.06 0 00-.116-1.464.991.991 0 00-1.424.119z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-chevron-down" viewBox="0 0 16 16">
            <path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/>
        </symbol>
        <symbol id="icon-warning" viewBox="0 0 18 18">
            <path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-plus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-minus" viewBox="0 0 16 16">
            <path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-error" viewBox="0 0 18 18">
            <path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill="currentColor" fill-rule="evenodd"/>
        </symbol>
        <symbol id="icon-springer-arrow-left">
            <path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/>
        </symbol>
        <symbol id="icon-springer-arrow-right">
            <path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/>
        </symbol>
    </svg>

    </body>
</html>

